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Abbreviations 
ACA = anterior cerebral artery 
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FOME = Fuld Object Memory Evaluation 
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HVLT = Hopkins Verbal Learning Test 
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MOCA = Montreal Cognitive Assessment 
MMSE = Mini-Mental State Examination 
MWT-B = Mehrfach-Wahl-Wortschatz-Test 
NCT = Number Connection Test  
NVLT = Non-Verbal Learning Test 
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TIA = transient ischemic attack 
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WAIS-III = Wechsler Adult Intelligence Scale, third edition 
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General Introduction 
 
Stroke is the third leading cause of death in most western countries.1 Carotid stenosis, a 
narrowing of the internal carotid artery, has been identified as an important risk factor for stroke, 
with increasing risk depending on the severity of the stenosis.2 Carotid stenosis occurs when an 
atherosclerotic plaque builds up in the internal carotid artery. This plaque is made up of fat, 
cholesterol, calcium, and other substances found in the blood. Over time, the plaque hardens and 
narrows the carotid arteries. On one hand the carotid stenosis may limit or even block the blood flow 
towards the brain, resulting in an ischemic stroke. On the other hand, an ischemic stroke can also 
occur if a piece of plaque breaks away from the stenosis. The clot can migrate to the brain and get 
stuck in one of the brain’s smaller arteries, also causing an ischemic stroke. The prevalence of 
carotid stenosis increases with age in both men and women3 and with increasing life expectancy, 
this problem tends to become more important. Throughout this thesis, the term stroke will be used 
for ischemic stroke which is defined as an episode of neurological dysfunction caused by focal 
cerebral, spinal, or retinal infarction.4  
 
To reduce the risk of stroke, carotid endarterectomy (CEA), i.e. the surgical removal of the 
plaque, is performed and has shown to be effective in reducing stroke in patients with recent carotid 
territory symptoms5 as well as in asymptomatic patients.6 A patient with carotid artery stenosis is 
considered symptomatic if the patient has transient or permanent focal neurological symptoms 
related to the ipsilateral retina or the cerebral hemisphere such as amaurosis fugax, transient 
ischemic attack (TIA), or stroke.7 Asymptomatic patients are defined as patients with a significant 
carotid stenosis without these carotid territory symptoms. In CEA, the inner layer of the artery, 
intima and part of the media is removed (Figure 1). During the removal of the plaque, the internal 
carotid is clamped proximally and distally. A temporary shunt can be used to ensure sufficient blood 
flow to the brain during the procedure. Following recent guidelines, it is considered that patients 
with carotid territory symptoms within the past 6 months should undergo intervention when there is 
a stenosis of in ipsilateral internal carotid artery of at least 50%. For asymptomatic patients it is 
considered reasonable to perform CEA when there is at least a 70% stenosis of the internal carotid 
artery.8 Since CEA reduces the stroke risk by half in asymptomatic patients,6 CEA is carried out 
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regularly, although the debate whether asymptomatic patients on appropriate medical treatment 
should be treated invasively is still ongoing.9  
 
 
Figure 1. Carotid endarterectomy (CEA). A) Dissection of the carotid artery. B) Removal of the 
atherosclerotic plaque. C) Closure of the carotid artery with a patch.  
CCA = common carotid artery; ECA = external carotid artery; ICA = internal carotid artery 
Reproduced from Roffi et al.10 with permission of the publisher, Oxford University Press. 
 
Carotid artery stenting (CAS) may be an alternative for CEA, especially in high-risk patients 
for surgery, reducing cranial nerve injury, wound complications and possible negative effects of 
general anesthesia such as myocardial infarction.11 In CAS, a catheter is threaded up from the 
femoral artery into the internal carotid artery, where stenting and pre and/or post balloon dilatation 
is carried out (Figure 2). Distal embolic protection devices are often used to prevent cerebral 
embolization during CAS. Typically, a filter is deployed cranial/distal to the stenosis before 
angioplasty and stenting, and retrieved afterwards (Figure 3A). The use of prophylactic CEA and 
CAS with distal protection filters (CASdp) has been evaluated in many studies, and both methods 
are safe and effective options for stroke prevention in appropriately selected patients and if 
performed by proficient surgeons or endovascular therapists.12-14 CASdp is nonetheless associated 
with an increased risk of stroke and lesions on new diffusion-weighted magnetic resonance imaging 
(DW-MRI), compared with CEA.15, 16 
 
 
A B C 
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Figure 2. Carotid stenting (CAS). A) A guidewire crosses the stenosis in the internal carotid artery. B and 
C) the stent is deployed. D) Balloon post dilation is performed to expand the stent.   
CCA = common carotid artery; ECA = external carotid artery; ICA = internal carotid artery 
Reproduced from Roffi et al.10 with permission of the publisher, Oxford University Press. 
 
 
 
Figure 3. Cerebral protection methods used during carotid stenting. A) Distal embolic protection filters 
(CASdp). B) Distal balloon occlusion. C) Proximal protection established by balloon occlusion in the 
proximal common carotid and external carotid. 
CCA = common carotid artery; ECA = external carotid artery; ICA = internal carotid artery 
Reproduced from Roffi et al.10 with permission of the publisher, Oxford University Press. 
 
 
 
A B C 
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Trying to reduce these higher stroke and DW-MRI lesions rates, proximal protection methods 
have become increasingly popular (Figure 3C). The Mo.MA system (Medtronic Invatec, 
Roncadelle, Italy), inserted via the groin, blocks the antegrade flow to the internal carotid artery by 
proximal balloon occlusion in the distal segment of the common carotid and in the external carotid 
arteries (Figure 3C).17, 18 After dilation and stenting, the debris can be removed by active blood 
aspiration. Nonetheless, the beneficial effects of proximal balloon occlusion compared with distal 
filters are not observed universally.19, 20 
 
CAS with dynamic flow reversal via a direct cervical approach (CASfr) is a novel technique 
that is designed to provide a shorter, more direct access via the neck to deliver the stent and balloon. 
In this technique, the flow in the common carotid is blocked and reversed by an arteriovenous shunt 
created between the common carotid artery and the femoral vein (Figure 4 and 5). This flow 
reversal ensures that emboli flow away instead of towards the brain.21 CASfr gained increasing 
attention as manipulation in the aortic arch and the proximal common carotid artery is avoided and 
the lesion is not crossed until protection is in place, resulting in a reduced number of new DW-
MRI lesions caused by emboli showers typically observed during stenting and dilation using distal 
embolic protection devices.21-23  
 
 
Figure 4. CAS with dynamic flow reversal via a direct cervical approach (CASfr). 
 
 
Chapter 1 
18 
 
        
Figure 5. CAS with dynamic flow reversal via a direct cervical approach (CASfr). 
  
Carotid stenosis, carotid revascularization, and cognition 
 
Symptomatic as well as asymptomatic carotid artery stenoses have been described to be 
associated with cognitive disturbances.24, 25 Silvestrini et al.26 demonstrated that unilateral left and 
right-sided asymptomatic carotid stenosis affect cognitive abilities specific to the ipsilateral 
hemisphere. The presence of a significant carotid stenosis in asymptomatic patients is a robust 
predictor of cognitive dysfunction, regardless of possible silent DW-MRI lesions24 while no clear 
effect on cognition can be observed for low grade carotid stenoses (<25%).27 Reduced blood flow 
to the brain or silent infarctions due to microembolization from the carotid plaque may be the cause 
of these cognitive deficits.28 While it is clear that a significant carotid stenosis is associated with 
cognitive decline, it remains the question whether carotid revascularization can alleviate this 
problem.29 
 
Examining the effect of carotid revascularization procedures, such as CEA and CAS, on 
the cognitive status of the patient is a booming research topic. Any carotid revascularization may 
lead to cognitive decline caused by procedural emboli, general anesthesia (CEA), or temporary flow 
interruption due to clamping of the carotid artery (CEA) or balloon dilatation (CAS).29, 30 
Conversely, reopening a stenotic vessel and restoring blood flow to the brain may improve cognitive 
dysfunction caused by chronic hypoperfusion.29, 30 To date, it is still unclear whether these complex 
interactions ultimately result in a net improvement or a deterioration in the cognitive function.31 
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Several reviews about cognitive functioning after carotid revascularization have been published 
in 2007 and 2008.29, 30, 32, 33 The consensus stated that it was still unclear if carotid revascularization 
results in cognitive decline, improvement, or no change at all and that further research is necessary 
to clarify the effects of CEA and CAS. 
Several factors have contributed to this inconsistency. First, there is considerable variability in 
the demographical and clinical characteristics of patients, such as differences in symptoms (i.e. 
presence or absence of stroke), baseline cerebral perfusion status, age, sex, education, professional 
level, side and severity of stenosis, length of time between symptoms and revascularization, and 
medical, neurological and psychiatric histories.33 Second, study characteristics also vary widely, in 
particular the susceptibility of the design to learning and practice effects, type of tests used (and 
their inherent difference in sensitivity), timing of assessments, and failure to implement an 
appropriate control group. Other factors, like underpowered studies, and variability of surgical 
techniques and criteria used in detecting postoperative change also flaw these cognitive studies.29, 32 
 
In 2013 we performed a new review on this topic. For this review, we only included papers 
published since 2007 for two reasons. First, studies published before 2007 have already been 
discussed extensively in former reviews while no systematic overview of the recent literature has 
been reported since 2008. Second, because carotid treatment has continuously evolved, including 
evolution in medical devices (e.g. protection devices for CAS and type of stents) and drug therapy. 
Therefore, it is important to look at the recent papers in order to obtain a better ecological validity 
of the findings. Indeed, there seems to be a difference between the results of publications depending 
on the date of publication,29, 33 as older studies have a higher chance of finding positive results. As 
De Rango et al.29 suggested, this might be the consequence of fewer methodological biases in more 
recent studies. 
 
In this systematic review, we focus on the neurocognitive consequences of carotid 
revascularization. We included all papers written in English focusing on the cognitive effects of 
carotid revascularization published between 2007 and May 2013. Searches were conducted on 
PubMed and Web of Science using the key word ‘carotid’ in combination with ‘cognitive’, 
’cognition’, ‘neurocognition’, ‘neurocognitive’, ‘neuropsychology’, and ‘neuropsychological’. 
References of included papers were cross-checked for other relevant papers. Only papers 
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investigating the effects of carotid revascularization (CEA and CAS) on the cognitive functions 
were retained; reviews were excluded. Papers were included when neurocognitive testing was 
carried out preoperatively and at least once postoperatively more than 5 days after carotid treatment. 
Studies that only examined the cognitive functions on the first postoperative days were excluded 
because anesthesia and type of postoperative medical care may heavily influence these short-term 
results. Indeed, by using event-related potentials, Mracek et al.34 found that general anesthesia had 
a negative effect on cognition the first postoperative day, but after 6 days no differences in cognitive 
functions were noted between general and local anesthesia. 
To ensure that studies conducted extensive neuropsychological testing, papers that only used 
short cognitive screening instruments, such as the Mini-Mental State Examination (MMSE) and the 
Montreal Cognitive Assessment (MOCA), were excluded. Furthermore, to assure that the studies 
were sufficiently powered, studies in which less than 15 patients adhered to follow-up, were 
excluded. Finally, studies that solely investigated the effects of revascularization of carotid 
occlusions were also excluded, since it may not be possible to extrapolate these results to non-
occlusive significant carotid artery stenoses. 
Studies were grouped into three categories: CEA alone, CAS alone, and CEA versus CAS. 
Results in these three categories are reviewed for common findings; a focus is given on papers with 
solid methodological setups, such as studies using the reliable change indices by calculating z-
scores: (individual test score – mean score of control group) / SD of control group. When simply 
comparing pre- and post-revascularization cognitive scores for both patient and control groups 
separately, results are heavily influenced by characteristics like sample size in both groups. Studies 
are given a superscript ‘a’ mark when they included a control group and compared the patient 
group(s) with this control group using statistical methods. A superscript ‘b’ mark was given when 
they included an adequately sized control group but did not compare the groups with each other 
directly. Underpowered control groups were defined as sample sizes of less than half of the patient 
sample size. Studies received a superscript ‘c’ mark when they did not implement a control group, 
or when they did but did not compare the groups directly, and when the control group contained less 
than half the amount of subjects in the patient group. All CEA versus CAS studies were reviewed 
because they have at least two groups, which allows a valid comparison between the two techniques. 
Of the studies only examining CEA or CAS, only studies that received a superscript ‘a’ or ‘b’ mark 
were reviewed in the Results section to ensure the focus is given on methodologically sound studies. 
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Sixty-seven studies were identified, of which 36 were included in this review. The papers 
excluded were 5 reviews, 5 having a too small sample size in follow-up assessments, 7 only using 
short screening instruments (MMSE or MOCA), 1 missing a preoperative assessment, 9 only 
providing follow-up data for a few days, and 2 focusing on intragroup differences and not reporting 
results of the whole group. Of the 38 remaining articles, 1 study35 was also excluded because of a 
large variation in the timing of the postoperative assessment. Patients were tested between 4 and 41 
months after intervention. Since the timing of postoperative testing can also be a confounding factor, 
results from this study are impossible to interpret and to compare with other studies. Another study36 
was left out of this review because it was a subgroup analysis of another paper already included.37 
So in total, 36 studies were included in this review of which 11, 3, and 22 received the superscript 
‘a’, ‘b’, and ‘c’ mark, respectively. 
Studies Comparing Neurocognitive Outcome after CEA versus CAS 
Five of the 7 studies comparing CEA with CAS found no significant differences in cognitive 
outcome between procedures11, 38-41 (table 1). Lal et al.42 also found no differences in the global 
cognitive score, but discovered that CEA resulted in a reduction in memory performance compared 
with CAS, while CAS patients showed reduced psychomotor speed. Wasser et al.37 also found no 
significant differences in the global difference score, but the domain verbal learning showed a small 
improvement for CAS compared with CEA. 
Although this review contains 2 studies focusing on symptomatic, 2 on asymptomatic, and 3 on 
symptomatic as well as asymptomatic patients, and some studies even randomized the patients to 
CEA and CAS, all these studies concluded that CAS and CEA have a comparable effect on cognition 
in asymptomatic and symptomatic patients. 
When looking at the results for CAS and CEA separately compared to healthy controls and 
applying the methodological criteria described previously, only 2 of the 7 studies are eligible and 
both used an extensive neuropsychological test battery (table 1; 2 studies with a superscript ‘a’ 
mark). Wasser et al.37 found that both patients after CAS and after CEA deteriorated significantly 
over time in the domain short-term memory and in visuoconstructive functions compared to 
controls. Altinbas et al.38 found for CAS, but not for CEA, a small but significant decrease in the 
total cognitive sum score. 
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Table 1. Studies comparing neurocognitive outcome after CEA versus CAS 
       
       
Reference Patients in 
follow-up 
Control 
group  
Follow-
up 
period 
Cognition after CEA versus 
CAS 
Control for 
effect of 
previous stroke 
on cognition 
Cognitive domains and 
tests  
       
       
Witt et 
al.11, 
2007c  
45  
24 CEA vs. 
21 CAS 
without 
CPD 
Randomized 
Sympt. 
No 6 and 30 
days 
No differences between 
CEA and CAS at 6 or 30 
days 
At 6 days:  
Decline in 19% of CEA vs. 
21% of CAS 
Improvement in 25% of 
CEA vs. 14% of CAS in 2 
or more tasks 
At 30 days: 
Decline in 25% of CEA vs. 
24% of CAS  
Improvement in 29% of 
CEA vs. 24% of CAS in 2 
or more tasks 
CAS: 33% 
stroke  
CEA: 50% 
stroke  
No differences 
in frequency 
stroke between 
groups 
Verbal memory: 
RAVLT 
Non-verbal memory: 
CFT-R 
Attention: Paced Visual 
Serial Addition Test, 
TMT (A and B), 
Modified Stroop  
Executive function: 
verbal fluency 
(phonologic and 
semantic), RNGT 
Motor skills: Purdue 
Pegboard Test, Finger-
Tapping Test 
              Takaiwa 
et al.39, 
2009c 
26  
11 CEA vs. 
15 CAS 
with CPD 
No 
randomizati
on 
Asympt. + 
sympt. (45% 
CEA, 60% 
CAS)  
No 1 week, 
3, 6, and  
12 
months 
No significant differences 
between CEA and CAS for 
any of the domains or 
MMSE  
Only CEA showed decrease 
at 1 week 
At 1 week:  
CEA: 36% of patients 
showed decrease for 
immediate as well as 
delayed memory, 
visuospatial construction, 
language, and total score 
CAS: 13% showed decrease 
for visuospatial construction 
and language / 36% showed 
improvement for immediate 
and delayed memory, and 
total score  
At 3, 6, and 12 months:  
Improvement in 54% of 
CEA vs. 67% of CAS 
No deterioration 
No differences 
in frequency 
symptomatic 
status between 
groups 
MMSE 
RBANS (immediate 
memory, visuospatial 
construction, language, 
attention, delayed 
memory, and total 
score) 
       
       Feliziani 
et al.40, 
2010c 
46  
22 CEA vs. 
24 CAS 
with CPD 
No 
randomizati
on 
Asympt.  
No 3 and  
12 
months 
No significant differences 
between the groups over 
time for all studied variables 
No changes over time for 
CEA or CAS, except for a 
slight deterioration in 
visuospatial construction in 
the CAS group 
NA MMSE  
Memory: Babcock Story 
Recall, RAVLT, 
semantic fluency 
Attention and executive 
functions: TMT (A and 
B), COWAT 
Visuospatial 
construction: Copy 
Drawing Test 
              Altinbas 
et al.38, 
2011a  
119  
58 CEA vs. 
61 CAS (no 
info about 
CPD) 
Randomized 
Sympt.  
75 
healthy 
(historic
al 
control) 
6 
months 
No significant differences 
between CEA and CAS in 
any of the domains 
No changes in any of the 6 
domains for CAS or CEA 
A small but significant 
decrease in cognitive sum 
score for CAS, but not for 
CEA  
CAS: 42% 
stroke CEA: 
51% stroke 
No differences 
in frequency 
stroke between 
groups  
NRT, MMSE 
Abstract reasoning: 
WAIS-III similarities, 
RAPM 
Attention: WAIS-III 
digit span (f), Visual 
Elevator of the Test of 
Everyday Attention 
Executive functioning: 
BSAT, letter fluency 
Language: TT, BNT 
Verbal memory: WAIS-
III digit span (b), 
RAVLT, semantic 
fluency 
Visual memory: CFT-R 
Visual perception: JLO, 
FRT, CFT-R (copy) 
Neglect: Star 
Cancellation Test 
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Lal et 
al.42, 
2011c 
46 
25 CEA vs. 
21 CAS 
with CPD 
No 
randomizati
on 
Asympt. 
No  4–6 
months 
No differences on composite 
change score for CEA and 
CAS. Both groups showed 
improvement on composite 
change score and each 
individual test 
  
Impairment only observed 
in CEA for working 
memory index and CAS for 
psychomotor speed. No 
differences between CEA 
and CAS on other tests 
NA TMT  
Processing speed index 
(digit symbol coding 
and symbol search) of 
WAIS-III  
Working memory index 
(letter-number 
sequencing and spatial 
span) of WAIS-III  
BNT  
COWAT  
HVLT 
              Wasser et 
al.37, 
2011a 
55  
31 CEA vs. 
24 CAS 
(CPD in 9 of 
24) 
No 
randomizati
on 
Asympt. + 
sympt. (71% 
CAS, 39% 
CEA)  
27 
healthy 
Matched 
(age and 
educatio
n) 
3 
months 
No significant differences 
between the groups on 5 of 
the 6 domains. Only verbal 
learning showed an 
improvement for CAS 
whereas CEA showed 
deterioration 
 
Both groups deteriorated 
significantly over time in the 
domain of short-term 
memory, and 
visuoconstructive functions 
CEA: 16% 
stroke CAS: 
30% stroke 
No differences 
in frequency 
stroke between 
groups 
MMSE 
Attention: TAP 
(alertness and divided 
attention)  
Short-term memory: 
TAP (working 
memory), SRT, WMS-R 
Executive functions: 
RWFT, WCST, 
Regard’s Five Point 
Test 
Verbal learning and 
memory: SRT, WMS-R, 
Non-verbal learning and 
memory: CFT-R 
(recall), lNVLT, Spatial 
Recall Test 
Visuoconstructive 
functions: CFT-R (copy) 
              Zhou et 
al.41, 
2012c 
51  
35 CEA vs. 
16 CAS 
with CPD 
No 
randomizati
on 
Asympt. + 
sympt. (54% 
CEA, 50% 
CAS)  
No  1 month No differences between the 
groups on test scores 
No statistical methods were 
used to evaluate cognitive 
impairment or improvement 
CEA: 20% 
stroke 
CAS: 25% 
stroke  
No differences 
in frequency 
stroke between 
groups 
ART 
MMSE 
Memory: RAVLT 
Attention and executive 
function: TMT, Digit 
Span, color-word 
interference  
Language: category 
fluency, BNT,  
Motor skills: GP 
(no information about 
results of tests in italic) 
       
 Author names in bold means the study was reviewed. NA = Not applicable; CPD = cerebral protection device; WAIS-III = 
Wechsler Adult Intelligence Scale, third edition; WMS-R = Wechsler Memory Scale Revised; CFT-R = Rey Complex Figure 
Test; RAVLT = Rey Auditory Verbal Learning Test; HVLT = Hopkins Verbal Learning Test; RBANS = Repeatable Battery for 
the Assessment of Neuropsychological Status; GP = Grooved Pegboard; RWFT = Regensburger Word Fluency Test; NVLT = 
Non-Verbal Learning Test; SRT = Selective Reminding Test; TAP = Test Battery for Attentional Performance; JLO = Judgement 
of Line Orientation; RNGT = Random Number Generation Task; FRT = Facial Recognition Task; RAPM = Raven Advanced 
Progressive Matrices; TT = Token Test; BSAT = Brixton Spatial Anticipation Task; TMT = Trail Making Test; COWAT = 
Controlled Oral Word Association Test; BNT = Boston Naming Test; WCST = Wisconsin Card Sorting Test; ART = Adult 
Reading Test. 
a Using statistical methods to compare the patient and control group. c No control group, or calculating differences for the 
patient and control group over time separately, with a control group that contains less than half the number of the patient group. 
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Studies on Neurocognitive Outcome following CEA 
Ten43-52 of the 17 studies43-59 examining the effects of CEA fulfilled our criteria (table 2; 8 
studies with a superscript ‘a’ mark and 2 with a superscript ‘b’ mark). The Department of 
Neurosurgery of the Iwate Medical University published several papers on the cognitive 
consequences of CEA, all using established tests of intelligence and memory. Studies that examined 
cognitive deterioration found impairment in 13% of patients after CEA,44, 47 while studies focusing 
on cognitive amelioration after CEA found improvement in 10% of the cases.45, 46 One study 
evaluated both trends and noted improvement in 10% and impairment in another 10% of the patients 
in one or more cognitive domains.43 All these studies thus found comparable results. 
Other research groups found mixed results with no change,52 or a decrease in cognitive score in 
6%50 or even 15% of patients49. 
In the studies comparing patient groups with control groups separately, Czerny et al.51 found an 
improvement over time for the patient group on the Number Connection Test at 1 year but not after 
5 years. At 1 month after intervention, Soinne et al.48 observed cognitive impairment in 11% of CEA 
patients but in 0% of the controls.  
We can summarize that in most studies, a decrease in the cognitive score over time is found in 
10-15% of patients after CEA. Improvements are also often observed in about 10% of patients.  
 
Table 2. Studies on neurocognitive outcome after CEA 
       
       
Reference Patients in 
follow-up 
Control 
group  
Follow-up 
period 
Cognition after CEA Control for 
effect previous 
stroke on 
cognition 
Cognitive domains and 
tests 
       
       
Bossema 
et al.52 
2007a 
45 CEA  
(20 lCEA 
and  
25 rCEA) 
Asympt. + 
sympt. 
(lCEA: 
45%, 
rCEA: 
76%) 
25 healthy 
(similar 
education, 
age, and 
hand 
dominanc
e)  
3 months No interactions between 
time and group. Both 
groups improved 
equally  
No difference between 
patients and controls on 
reliable changes after 
CEA 
No stroke 
included 
Dichotic Listening Test 
Finger Tapping Test 
Motor Planning Test / 
Verbal Fluency Test 
(COWAT + category) 
Doors Test 
              Saito et 
al.55, 
2007c 
55 CEA 
Asympt. + 
sympt. 
(62%) 
20 patients 
(neck 
clipping 
through 
craniotom
y) 
1 month Impairment: 11% in one 
or more cognitive 
domains (only 
impairments were 
assessed) 
44% stroke 
No symptoms 
<1 month  
No significant 
differences 
between groups 
(impairment / no 
impairment) for 
symptomatic 
status 
WAIS-R (verbal IQ + 
performance IQ) 
WMS 
CFT-R (copy + recall) 
              Falkensam
mer et 
al.59, 
2008c 
19 CEA at 
7–10 days 
16 CEA at 
6 months 
Asympt. 
No  7–10 days, 
6 months 
Overall improvement at 
7–10 days and 6 
months. 3 patients 
showed decline (1 with 
NA Fine motor 
coordination: GP 
Expressive language: 
COWAT, category 
fluency 
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reliable change indices 
= 6%)  
Significant 
improvement in digit 
symbol, verbal memory. 
Conversely, there was a 
significant decline on 
one test assessing 
processing speed at 6 
months (word reading in 
SCWT) 
Verbal memory: 
RAVLT 
Mental status screen: 
MMSE 
Estimated premorbid 
verbal IQ: ART 
Processing 
speed/attention/executiv
e function: Digit Span 
and Digit Symbol 
(WAIS-R), TMT (A and 
B), SCWT, D-KEF 
Sorting Test 
              Hirooka et 
al.54, 
2008c 
158 CEA 
Asympt. + 
sympt. 
(70%)  
No 1 month Impairment: 11% on 1 
or more of 5 domains 
(only impairments were 
assessed) 
51% stroke  
No control for 
stroke or 
symptomatic 
status 
WAIS-R (verbal IQ + 
performance IQ) 
WMS 
CFT-R (copy + recall) 
              Chida et 
al.44, 
2009a 
60 CEA 
Asympt + 
Sympt 
(62%)  
44 patients 
(neck 
clipping 
through 
craniotom
y; 
historical 
control) 
1 month Impairment: 13% in one 
or more of 5 domains 
(only impairments were 
assessed) 
43% stroke 
No significant 
differences 
between groups 
(impairment / no 
impairment) for 
symptomatic 
status 
WAIS-R (verbal IQ + 
performance IQ) 
WMS 
CFT-R (copy + recall) 
              Soinne et 
al.48, 
2009b 
44 CEA 
Asympt. + 
sympt. 
(48%)  
22 healthy 
Matched 
(sex, age, 
education, 
and social 
class) 
100 days Equal improvement for 
CEA and controls  
At 100 days: 
Impairment: CEA, 5 
patients (11%) vs. 
controls, 0%  
 
On the domain level: 
attention 48% of CEA 
vs. 18% of controls had 
impairment 
(significant), motor 
dexterity, 32% of 
patients vs. 18% of 
controls (NS)  
15% minor 
stroke 
No control for 
stroke on 
cognition 
Language: BNT  
Verbal memory and 
learning: RAVLT 
Immediate verbal 
memory: WAIS-R Digit 
Span –F and B 
Verbal fluency: word 
and category naming 
Visual memory: CFT-R 
– Visual Design 
Learning Test 
Immediate visual 
memory: Corsi Blocks F 
and B 
Attention: Letter 
Cancellation Task, TMT 
(A) 
Executive function: 
Stroop Test, TMT (B) 
Motor dexterity: Purdue 
Pegboard 
              Yocum et 
al.49 2009a 
149 CEA 
Asympt. + 
sympt. (no 
percentage
s are 
given) 
60 patients 
(lumbar 
spine 
surgery) 
1 month At 1 month:  
moderate to severe 
cognitive deterioration: 
16% (10% severe, 6% 
moderate)  
No information 
is given about 
symptoms 
Verbal function: BNT 
Verbal fluency: 
COWAT 
Visuospatial 
construction: CFT-R 
(copy) 
Visuospatial memory: 
CFT-R (recall) 
Complex conceptual 
switching: TMT (B) 
Attention: TMT (A) 
Verbal learning and 
memory: HVLT or 
BSRT  
              Chida et 
al.45, 
2010a 
79 CEA 
Asympt. + 
sympt. 
(59%)  
70 healthy  1 month Improvement: 9% in 
one or more of 5 
domains (only 
improvements were 
assessed) 
19% stroke 
No symptoms 
<2 weeks 
No significant 
differences 
between groups 
(improvement / 
no 
improvement) 
for symptomatic 
status or stroke 
WAIS-R (verbal IQ + 
performance IQ) 
WMS 
CFT-R (copy + recall) 
              Czerny et 
al.51, 
2010b 
25 CEA 
Asympt. + 
sympt. 
(60%) 
25 healthy 
Matched 
(age and 
sex) 
1 and  
5 years 
Improvement for patient 
group at 1 and 5 years 
on the NCT 
No changes on MMSE 
No stroke 
included  
MMSE  
NCT 
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Gigante 
et al.50, 
2011a 
127 CEA 
Asympt. + 
sympt. 
(4%) 
71 patients 
(lumbar 
laminecto
my / 
similar 
age and 
education)  
30 days At 30 days: 
Moderate to severe 
deterioration: 6%  
No information 
is given about 
the type of 
symptoms in the 
symptomatic 
patients 
Verbal function: BNT 
Verbal fluency: 
COWAT 
Visuospatial 
construction: CFT-R 
(copy) 
Visuospatial memory: 
CFT-R (recall) 
Complex conceptual 
switching: TMT (B) 
Attention: TMT (A) 
Verbal learning and 
memory: HVLT or 
BSRT 
Manual dexterity: GP 
              Ghogawal
a et al.53, 
2013c 
23 CEA 
(at 1 
month) 
20 CEA at 
6 months 
19 CEA at  
12 months 
Asympt. + 
sympt. 
(21%)  
No  1, 6, and  
12 months 
At 1 month:  
Improvement: 30% 
Deterioration: 30–40% 
on TMT (A and B) and 
HVLT 
At 12 months: 
significant improvement 
for all tests  
Improvement: 60%  
No stroke 
included 
Attention: TMT (A) 
Executive functioning: 
TMT (B) 
Verbal fluency: 
COWAT 
Verbal learning and 
memory: HVLT 
              Nanba et 
al.47, 
2012a 
70 CEA  
Asympt. + 
sympt. 
(71%)  
44 patients 
(neck 
clipping 
through 
craniotom
y; 
historical 
control) 
1 month Deterioration: 13% in 
one or more of 5 
domains (only 
impairments were 
assessed) 
31% stroke 
No symptoms 
<2 weeks 
No significant 
differences 
between groups 
(impairment / no 
impairment) for 
symptomatic 
status  
WAIS-R (verbal IQ + 
performance IQ) 
WMS 
CFT-R (copy + recall) 
              Yamashit
a et al.46, 
2012a 
140 CEA 
Asympt. + 
sympt. 
(69%)  
70 healthy 
(historical 
control) 
1 month Improvement in 10% of 
patients in one or more 
of 5 domains (only 
improvements were 
assessed) 
No symptoms 
<2 weeks 
No significant 
differences 
between groups 
(improvement / 
no 
improvement) 
for symptomatic 
status  
WAIS-R (verbal IQ + 
performance IQ) 
WMS 
CFT-R (copy + recall) 
              Yosida et 
al.56, 
2012c  
213 CEA 
Asympt. + 
sympt. 
(65%)  
40 healthy  1–2 
months  
Improvement: 13% 
Deterioration: 12% 
No symptoms 
<2 weeks 
No control for 
stroke on 
cognition 
WAIS-R (verbal IQ + 
performance IQ) 
WMS 
CFT-R (copy + recall) 
              Inoue et 
al.57, 
2013c 
81 CEA 
Asympt. + 
sympt. 
(54%)  
No 6 months Significant 
improvement for all 
scores (VIQ, PIQ, 
WMS-memory and 
WMS-attention) 
No information 
about stroke 
tendency of 
positive effect 
of symptomatic 
status on 
progress 
WAIS-R (verbal IQ + 
performance IQ) 
WMS (memory + 
attention) 
              Saito et 
al.43, 
2013a 
100 CEA  
Asympt. + 
sympt. 
(64%) 
40 healthy 
(historical 
control) 
1 month Improvement: 10% 
Impairment: 10% in one 
or more of the 5 
cognitive scores  
No symptoms 
<2 weeks 
No significant 
differences 
between groups 
(improvement / 
deterioration) 
for symptomatic 
status 
WAIS-R (verbal IQ + 
performance IQ) 
WMS 
CFT-R (copy + recall)  
              Takaiwa 
et al.58, 
2013c 
15 CEA  
Asympt. 
No 3 months Improvements in 
immediate memory, 
attention, total scale of 
the RBANS, and 2 
subtests of WAIS-R  
Improvement: 30%  
Deterioration: 7% in 
RBANS and WAIS-R 
subtest scores  
NA RBANS (immediate 
memory, visuospatial 
construction, language, 
attention, delayed 
memory, and total 
score) WAIS-R 2 
subtests (information 
and picture completion)  
ART 
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Author names in bold means the study was reviewed. NA = Not applicable; WAIS-R = Wechsler Adult Intelligence Scale Revised; 
WMS = Wechsler Memory Scale; CFT-R = Rey Complex Figure Test; RAVLT = Rey Auditory Verbal Learning Test; HVLT = 
Hopkins Verbal Learning Test; BSRT = Buschke Selective Reminding Test; RBANS = Repeatable Battery for the Assessment of 
Neuropsychological Status; GP = Grooved Pegboard; NCT = Number Connection Test; TMT = Trail Making Test; COWAT = 
Controlled Oral Word Association Test; BNT = Boston Naming Test; ART = Adult Reading Test; SCWT = Stroop Color and Word 
Test; D-KEF = Delis-Kaplan Executive Function.  
a  Using statistical methods to compare the patient and control group. b  Calculating differences for the patient and control group 
over time separately, the control group contains more than half the number of the patient group. c  No control group, or calculating 
differences for the patient and control group over time separately, with a control group that contains less than half the number of the 
patient group. 
 
Studies on Neurocognitive Outcome after CAS 
Only 260, 61 of the 1260-71 included studies examining the effects of CAS fulfilled our 
methodological criteria regarding control groups (table 3; 1 study with a superscript ‘a’ mark and 1 
with a superscript ‘b’ mark). Xu et al.61 implemented a relevant control group that underwent a 
carotid angiography to correct for practice effects. They used an extensive neuropsychological 
battery. Only verbal memory showed better results over time in the CAS group; no deterioration in 
the other tests was observed. Ishihara et al.60 did not use a reliable change index to measure 
differences over time in the CAS group, but they had two different control groups. They found 
differential effects for right-sided CAS (improvement in performance IQ and delayed memory) and 
left-sided CAS (improvement in verbal IQ). The first control group undergoing neck clipping 
through craniotomy had minor and nonsignificant increases in the Wechsler Adult Intelligence Scale 
(third edition) and the Wechsler Memory Scale scores. The second control group with 
atherosclerotic disease displayed no cognitive changes over time, but this was a smaller group and 
thus had lower statistical power. Though there are only 2 studies methodologically solid enough to 
draw conclusions, small, but positive results are found over time for CAS patients. The problem of 
the lack of methodologically solid studies can also be observed in the review of De Rango et al.29. 
Only few studies have been published investigating the cognitive consequences of CAS, and even 
fewer have recruited a control group. 
 
Table 3. Studies on neurocognitive outcome after CAS 
       
       
Reference Patients in 
follow-up 
Control 
group 
Follow-up 
period 
Cognition after CAS Control for effect 
of previous stroke 
on cognition 
Cognitive domains and 
tests 
       
       
Xu et 
al.61, 
2007a 
51 CAS with 
CPD at 1 
week 
47 CAS with 
CPD at 12 
weeks 
Asympt. + 
sympt. (no 
percentages 
are given) 
57 patients 
(carotid 
angiograp
hy) 
1 and  
12 weeks 
CAS patients performed 
better on the RAVLT at 
1 as well as 12 weeks  
At 1 week but not at 12 
weeks, CAS patients 
showed deterioration in 
BNT  
No stroke <1 
month  
Both groups had 
similar percentage 
of stroke 
RAVLT 
CFT-R 
BNT 
Digit Span (WAIS)  
TMT  
Finger Tapping Test 
MMSE 
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       Mlekusch 
et al.63, 
2008c 
71 CAS with 
CPD 
Asympt. + 
sympt. (6%) 
No 6 months Significant 
improvement for TMT 
(A) 
Improvement: 45% (at 
least 2 tests) 
Deterioration: 8%  
No stroke patients 
included 
MMSE 
Attention: TMT (A and 
B) 
Verbal intelligence and 
fluency: COWAT + 
semantic  
              Turk et 
al.68, 
2008c 
17 CAS (no 
info about 
CPD) 
Asympt. + 
sympt. (76%) 
No  3 months Total RBANS score, 
immediate memory and 
attention improved 
35% stroke 
No control for 
stroke 
MMSE 
RBANS 
TMT 
              Tiemann 
et al.65, 
2009c 
22 CAS 
without CPD 
Asympt. 
No  6 weeks Improvement: LLT  
Deterioration: Digit 
span Tendency to 
improvement: phonemic 
verbal fluency 
Improvement: 36%  
Deterioration: 27%  
NA MWT-B, LLT, 
NCT, Digit Span (F and 
B), Spatial Span (F and 
B) 
Verbal fluency: 
phonological and 
semantical 
Block-Design-Test 
(WAIS) 
              Grunwald 
et al.64, 
2010c 
41 CAS 
without CPD 
Asympt. 
7 patients 
(endovasc
ular 
treatment 
ACA 
aneurysms
) 
3 months CAS: significant 
increase in cognitive 
speed but not memory  
Control group: no 
significant differences 
NA MMSE 
Cognitive speed: NCT, 
Labyrinth Test, Figure-
Symbol Test, Color-
Word Test 
Memory: Repeat the 
Numbers Test, Word 
List Test, Image Test, 
Word Pairs Test, 
Symbol Test, Latent 
Learning Test 
              Raabe et 
al.67, 
2010c 
62 CAS with 
CPD (51 at 3 
months, 48 at 
6 months, and 
51 at 12 
months) 
Asympt. + 
sympt. (31%) 
No  3, 6, and  
12 months 
At 3 months:  
16% improvement, 82% 
stable, 2% decline  
At 6 months:  
21% improvement, 71% 
stable, 8% decline 
At 12 months:  
22% improvement, 78% 
stable, 0% decline 
No major stroke 
26% minor stroke 
No effect of 
symptomatic 
status on cognition 
No control for 
stroke 
DRS-2 
RAVLT 
TMT (B) 
ART 
MMSE 
              Murata et 
al.69, 
2011c 
16 CAS with 
CPD 
Sympt.  
16 healthy 1 month No differences for total 
score RBMT. No scores 
for control group are 
provided  
No info about 
stroke  
No control for 
stroke 
RBMT  
              Chen et 
al.62, 
2012c 
34 CAS with 
CPD [divided 
into I (n = 6): 
ipsilateral 
ischemia and 
failed CAS; II 
(n = 17): 
ipsilateral 
ischemia and 
successful 
CAS, and III 
(n =11): no 
ischemia and 
successful 
CAS] 
Asympt. 
No 3 months Only group II showed 
significant improvement 
in ADAS-cog, MMSE 
and CTM (A) 
No changes for CTM 
(B) and semantic 
fluency  
No significant changes 
for groups I and III 
NA MMSE 
Alzheimer's Disease 
Assessment Scale 
cognitive subscale  
CTM (A and B) 
Semantic fluency 
              Mendiz et 
al.71, 
2012c  
20 CAS with 
CPD 
Asympt.  
No  3 months Improvement in set 
shifting (TMT B), 
processing speed (digit 
symbol coding and 
symbol search), and 
working memory (digit 
span backwards), verbal 
(RAVLT acquisition) 
and visual memory 
(CFT-R delayed score)  
The other tests revealed 
no differences  
NA MMSE 
ACE-R 
BNT  
Verbal fluency: 
phonologic and 
semantic 
RAVLT 
CFT-R 
Digit Span (F and B) 
TMT (A and B)  
WCST 
INECO Frontal 
Screening, Digit 
Symbol Coding 
(WAIS-III) 
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Symbol Search (WAIS-
III) 
              Cheng et 
al.66, 
2013c 
144 CAS (no 
info about 
CPD) – all 
MCI patients 
Asympt. + 
sympt. (55%) 
No 
randomization 
64 MCI 
patients 
(carotid 
stenosis 
on drug 
therapy)  
Asympt. + 
sympt. 
(56%) 
6 months CAS group: small but 
significant 
improvements in 
MMSE, MOCA, FOME 
and digit span. Rapid 
verbal retrieval showed 
no significant 
differences 
No significant changes 
for the control group  
No stroke <4 
weeks 
Both groups had 
similar % of 
stroke 
MMSE 
MOCA 
FOME 
Rapid verbal retrieval 
digit span (WAIS) 
              Ishihara 
et al.60, 
2013b 
39 (21 rCAS, 
18 lCAS) with 
CPD 
Asympt. + 
sympt. (no 
percentages 
are given) 
2 control 
groups: 
(a) 17 
patients 
(neck 
clipping 
through 
craniotom
y),  
(b) 12 
patients 
(atheroscl
erotic 
carotid 
artery 
disease)  
6 months IQ performance and 
delayed memory 
improved after rCAS 
VIQ improved after 
lCAS 
Group A: slight but not 
significant increases in 
most WAIS-III and 
WMS scores  
Group B: no significant 
changes in the WAIS-III 
or WMS scores  
No stroke <3 
months 
No control for 
stroke on 
cognition  
WAIS-III (verbal IQ, 
performance IQ, and 
full IQ)  
WMS-R (general 
memory, verbal 
memory, delayed 
memory, visual 
memory, attention, and 
concentration)  
              Ortega et 
al.70, 
2013c 
33 CAS with 
flow reversal 
Asympt. + 
sympt. (50%) 
No  6 months Global improvement, 
mainly information 
processing speed, 
language, memory and 
visuospatial function 
48% stroke 
Global score 
improved for 
patients with and 
without previous 
stroke 
Digit Span (WAIS-III),  
WMS-III Mental 
Control (attention) 
BNT 
Token Test 
Verbal fluency: 
COWAT and Semantic 
Fluency 
CVLT 
GP 
JLO 
SCWT  
       
       
Author names in bold means the study was reviewed. NA = Not applicable; CPD = Cerebral Protection Device. WAIS-III = 
Wechsler Adult Intelligence Scale, third edition; WMS = Wechsler Memory Scale; CFT-R = Rey Complex Figure Test; RAVLT = 
Rey Auditory Verbal Learning Test; RBANS = Repeatable Battery for the Assessment of Neuropsychological Status; MOCA = 
Montreal Cognitive Assessment; GP = Grooved Pegboard; NCT = Number Connection Test; RBMT = Rivermead Behavioral 
Memory Test; CVLT = California Verbal Learning Test; JLO = Judgement of Line Orientation; FOME = Fuld Object Memory 
Evaluation; CTM = Color Trail Making Test; ACE-R = Addenbrooke’s Cognitive Examination Revised; LLT = List Learning Test; 
TMT = Trail Making Test; COWAT = Controlled Oral Word Association Test; BNT = Boston Naming Test; WCST = Wisconsin 
Card Sorting Test; ART = Adult Reading Test; SCWT = Stroop Color and Word Test; MWT-B = Mehrfach-Wahl-Wortschatz-Test; 
ACA = anterior cerebral artery. 
a Using statistical methods to compare the patient and control group. b Calculating differences for the patient and control group 
over time separately, the control group contains more than half the number of the patient group. c No control group, or calculating 
differences for the patient and control group over time separately, with a control group that contains less than half the number of the 
patient group. 
 
Symptomatic Status 
Some papers only included asymptomatic patients, some admitted symptomatic patients without 
major (and minor) stroke, and others included all types of symptomatic patients. Sadly, several 
studies failed to provide information about the symptomatic status and type of symptoms in their 
patients. Furthermore, differences in timing between the symptoms and intervention can also 
influence the results. 
As previously stated, symptomatic status does not seem to have an influence on the cognitive 
differences or similarities found between CAS and CEA. Many studies reported no differences 
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related to symptomatic status or history of stroke between groups improving or deteriorating after 
CEA43-47, 55. In contrast, Inoue et al.57 reported a (nonsignificant) tendency of a positive effect of 
symptomatic status on cognition after CEA. For CAS, symptomatic status also does not seem to 
influence cognitive results.67 Furthermore, Ortega et al.70 found an improvement in global cognitive 
score for patients with, as well as without, previous stroke. It appears that symptomatic status does 
not have a clear impact on cognition after carotid revascularization.  
Side of Intervention 
For CEA, the side of carotid intervention does not have an influence on cognitive function. By 
using neuropsychological instruments sensitive to hemispheric specialization, Bossema et al.52 
demonstrated convincingly that changes in cognition occurred irrespective of the side of 
intervention. Furthermore, many studies found no difference in the side of intervention between 
groups improving or groups deteriorating postoperatively.45, 46, 55, 57 
In CAS, results are less consistent. Grunwald et al.64 and Turk et al.68 found no correlation 
between the cognitive results and the side of the intervention. On the other hand, Ishihara et al.60 
and Ortega et al.70 found differential effects for left and right sided CAS. Ishihara et al.60 noted that 
the performance IQ improved after CAS in patients with severe right-sided carotid artery stenosis 
while the verbal IQ rose after endovascular treatment of the left carotid artery. Ortega et al.70 found 
a significant increase in the global cognitive score, more specifically in language, visuospatial 
function, and information processing for left CAS, while patients with right CAS only presented a 
(nonsignificant) trend toward global cognitive improvement.  
Age 
In large studies and systematic reviews, age has been shown to be a predictor of postoperative 
cognitive dysfunction after noncardiac surgery.72, 73 For CAS and CEA, it was also shown that 
increasing age may raise the risk of cognitive decline,67, 74 though not all studies found a clear effect 
of age on the evolution of cognition after CAS.63, 64, 68, 70 
Wasser et al.36 found that older patients seem to be particularly vulnerable to cognitive decline 
after CEA, while CAS seems to have better results at follow-up. Feliziani et al.40, however, did not 
find these differences between CEA and CAS in elderly patients. In addition, increased neurological 
complications occur in the elderly after CAS in comparison to CEA, hence a patient-tailored 
approach seems mandatory to reduce stroke and death risk in this high-risk group.12, 75 
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New Brain Lesions after Revascularization 
As Schnaudigel et al.15 showed in their systematic review, CAS is more frequently associated 
with new DWI lesions compared with CEA (37 vs. 10%). These findings were supported by several 
recent studies37, 38, 41, 76. In a randomized trial, Bonati et al.16 also found that three times more patients 
in the CAS group than in the CEA group had new ischemic lesions (DW-MRI) on post-treatment 
scans. Schnaudigel et al.15 concluded that the use of cerebral protection devices (33 vs. 45% without) 
and closed-cell designed stents during CAS (31 vs. 51% with open-cell stents), as well as selective 
versus routine shunt usage during CEA (6 vs. 16%, respectively) significantly reduced the incidence 
of new ipsilateral DW-MRI lesions. 
Remarkably, numerous studies have failed to find an association between the incidence, the 
number, and the volume of new DW-MRI lesions and changes in cognition for CAS as well as 
CEA.37, 48, 54, 57, 60, 64, 65, 67 It seems that DW-MRI does not capture all damage that may evoke 
cognitive deterioration, and some DW-MRI lesions may have little functional impact. 
 
Perioperative embolization  
TCD is a noninvasive technique in which an ultrasonic beam is aimed at the cerebral arteries 
via natural openings or ‘windows’ of the skull. Ultrasound echoes generated by moving blood cells 
are recorded by the probe for offline analysis.77 By altering the depth of the sample volume and the 
direction of the beam, the middle cerebral artery (MCA) can be identified.77 TCD has been shown 
to be an effective tool when studying perioperative embolization during carotid revascularization.78 
In agreement with a higher prevalence of new DW-MRI lesions, CASdp has consistently been 
associated with a greater embolic load than CEA as detected by TCD, despite the use of distal 
protection devices.79-81 Although it has been shown that CASfr is capable of reducing the embolic 
showers that are typically observed in embologenic phases in CASdp such as stenting and balloon 
dilation,82 a direct comparison between CASfr and the other common revascularization procedures 
regarding their effect on perioperative embolization has not been published yet.  
 
The effect of perioperative embolization on postoperative cognitive functioning is unclear. 
Crawley et al.81 for example, found no correlation between the amount of emboli during CAS and 
CEA with neuropsychological outcomes. Martin et al.83 concluded in their systematic review that 
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the effect of perioperative embolization on cognition remains undecided. This may be the 
consequence of the variability in type (gaseous vs. particulate) and size of emboli. A few particulate 
emboli can be more damaging than several gaseous emboli.92 Therefore, differentiation between 
emboli may be valuable, but this is not easy as even the EmboDop which was designed to 
differentiate between gaseous and particulate emboli seems unreliable.84, 85  
 
S-100β 
S-100β is a neuroprotein that is present in the cytosol or on the membrane of astroglial 
cells.86 When the central nervous system is damaged, the serum concentration of S-100β increases 
as it leaks from the injured cells into the cerebrospinal fluid and subsequently across the impaired 
blood-brain barrier into the systemic circulation.87, 88 Hence, S-100β is a sensitive marker of 
cerebral injury and blood–brain barrier dysfunction.89-91 S-100β shows maximum levels within 24 
hours after cardiac surgery,92 has a biological half-life of approximately 25 minutes, and is rapidly 
excreted by the kidney.93 Because of the short half-life, most researchers tend to measure S-100β 
serum levels before, during, and several times within 12 to 24 hours after intervention.91, 94-96 It has 
been shown that elevated S-100β concentrations are associated with ischemic brain damage,92 
especially persisting elevated levels of S-100β 6 hours post intervention were related to 
neurological disturbances.94, 97, 98 Moreover, increased S-100B levels are correlated with 
symptomatic status.99 Transitory increases in S-100β serum levels appear, on the other hand, related 
to impairments in the blood-brain barrier without any neurological consequences.94, 95, 97, 98 S-100β 
rises in patients with focal brain damage after ischemic territorial MCA infarction,89 which makes 
this biomarker especially relevant to study cerebral damage after carotid revascularization because 
the MCA arises from the internal carotid. S-100β has therefore been studied in many carotid 
revascularization studies, but studies connecting S-100β to perioperative embolization assessed by 
TCD have reported conflicting results.96, 100  
Several studies have investigated the relation between S-100β concentrations and 
postoperative cognition.11, 59, 99, 101 Witt et al.11 found no elevated levels of S-100β early after 
carotid intervention, and thus no link between these levels and cognition after one month. Although 
Sahlein et al.101 did find higher S-100β concentrations due carotid intervention, no association was 
found with cognition one day postoperatively. Falkensammer et al.59 also failed to find an 
association between S-100β and cognition, but one of their twenty included patients showed 
neurological and cognitive disturbances postoperatively as well as persisting higher S-100β 
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concentrations after surgery. Connolly et al.86 detected a significant correlation between S-100β 
and cognition after one day, even in the absence of overt ischemic strokes. Based on the current 
literature, the relationship between increased S-100β levels during or early after carotid 
revascularization and postoperative cognition remains unclear.11, 59, 99, 101 Methodological issues 
such as only testing the patient one day postoperatively,86, 101 only using short cognitive screening 
instruments,91 or not assessing intra-operative S-100β levels11 make it difficult to compare the 
different studies.  
Other Findings Related to Postoperative Changes 
Using computed tomography perfusion, Cheng et al.66 found a close relation between perfusion 
changes and changes in cognitive performance. Patients undergoing CAS with baseline impairment 
of MCA blood flow were more likely to experience improvement in flow after revascularization. 
This MCA blood flow improvement was associated with greater cognitive improvement in attention 
and executive functioning.53 Repair of a presurgical low relative cerebral blood flow in the ipsilateral 
cerebral hemisphere has been shown to significantly improve postoperative cognitive function in 
patients undergoing CEA.45, 46 
Postoperative cognitive deterioration on the contrary seems significantly associated with 
postoperative hyperperfusion regardless of any new lesions on MRI.44, 47, 54 Similarly, cerebral 
hyperperfusion after CEA results in postoperative cerebral white matter damage (detected by 
diffusion tensor imaging), that is related to postoperative cognitive impairment.47 The available data 
show a link between cognition and postoperative perfusion changes for CAS as well as CEA. 
General remarks 
Several methodological issues arise from our review. In future research, we recommend to 
include a control group, preferably patients with asymptomatic carotid stenosis not undergoing 
revascularization. Although several researchers53, 58 correctly claim that different forms of material 
(i.e. different sets of the same test) reduce practice effects, patients become ‘test wise’. This can also 
result in significantly increased test scores over time.102 To increase the validity of the results by 
correcting for ‘test learning effects’, control groups are deemed necessary.103  
Furthermore, future research papers should be clear about the type of cerebral protection which 
was used and characteristics that are essential to interpret the results, such as symptomatic status. It 
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is for example important to reveal if symptomatic stroke patients are included since on the one hand, 
stroke patients may show better cognitive improvement due to neural reorganization that has nothing 
to do with revascularization. On the other hand, stroke patients could have fewer benefits of 
revascularization due to more permanent brain damage that is not alleviated by restored perfusion. 
When researchers decide to include stroke patients, it is essential to check whether stroke has an 
influence on the postoperative changes in order to rule out the fact that these changes are the result 
of stroke instead of the revascularization. Moreover, some researchers use changes in total scores to 
compare different groups while others employ scores in various domains. The latter is advised 
because some domains may improve while others may deteriorate, and a global cognitive score may 
not pick up these subtle differences. We recommend to report the percentage of patients in whom 
cognition improves and in whom cognition deteriorates. Finally, in order to reduce the high dropouts 
of patients during follow-up, we advise future researchers to test patients at home or to reduce the 
frequency and duration of the assessments. In the research projects proposed in this thesis, a special 
focus will be given to these issues to avoid similar methodological problems.   
 
In this review, we were not able to be strict on features like the type of control group. Healthy 
controls might not be an ideal comparison for patients with carotid artery disease, since these two 
groups are likely to differ on cardiovascular risk factors and general medical condition. Comparing 
carotid interventions to other interventions is a better alternative but still leaves the risk of 
confounding factors being responsible for the difference in results. An ideal comparison is that of 
patients with significant carotid stenosis undergoing revascularization and similar patients on best 
medical treatment, though for researchers advocating the usefulness of revascularization in 
asymptomatic patients, this may be difficult ethically. 
In comparison with former reviews, we focused on methodological criteria when interpreting 
the results, such as the use of a control group, comprehensive psychometric evaluation (not solely 
short screening instruments), and assessments beyond the early postoperative stage. From the 
review, it appears that CEA and CAS have a comparable effect on cognition. The inconsistency of 
the various studies has been explained throughout this review article with cognitive deterioration in 
10-15% of CEA patients, while an improvement of 10% of patients was also found regularly. 
Though there are limited methodologically solid studies examining the effects of CAS on cognitive 
General introduction and thesis outline 
35 
 
function, the studies provided show similar results. Nonetheless, there remains a need for larger, 
controlled prospective studies assessing cognition after carotid revascularization. 
Although cognition following intervention for carotid stenosis remains a matter for debate, it is 
an important outcome measure when comparing different treatments. As stated by Siddiqui and 
Hopkins104 and Huang et al.105, postoperative testing should be performed beyond 3 months to show 
lasting effects. Especially patients with baseline impaired cerebral perfusion could be a vulnerable 
cohort in which revascularization might enhance cognition.  
 
Following the former review, we have postulated several research questions that will form the 
basis of this thesis: 
 
1. Do CEA and CASdp result in similar cognitive outcomes? (Chapter 2) 
2. Does the newer stenting technique CASfr provide similar cognitive results as the established 
carotid revascularization therapies? (Chapter 2) 
3. Is there a measurable impact of carotid revascularization on cognition? (Chapter 2) 
4. Is it possible to predict cognitive outcome in order to detect patients at risk for cognitive decline 
or susceptible for cognitive improvement? (Chapter 3) 
5. Is S-100β a useful biomarker to differentiate between carotid revascularization therapies and 
predict cognitive outcome? (Chapter 3) 
6. Can perioperative embolization as recorded by TCD be used to differentiate between carotid 
revascularization therapies and predict cognitive outcome? (Chapter 3 and 4) 
7. Is CASfr able to reduce the higher embolic load observed in CASdp? (Chapter 4) 
8. Which procedural phases are at higher risk for perioperative embolization in the three treatment 
modalities? (Chapter 4)  
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Thesis Outline 
 
As reported above, the jury is still out there if CEA and CASdp have a similar impact on 
cognition.29, 106, 107. Both cognitive improvement and deterioration have been reported after either 
technique in 10 to 15% of patients.106 The impact of transcervical CAS with dynamic flow reversal 
on cognition is unclear. Ortega et al.70, 108 have shown promising results i.e. higher postoperative 
cognitive test scores after CASfr, but in the first study, there was no control group while in the 
second study normative data were used as a control group to assess cognitive changes after CASfr. 
Despite the fact that normative data are a good way to evaluate a cognitive performance at one 
point, they will not diminish the effect of possible confounders such as practice effects.  
 
To follow up on these outstanding questions, and taking the methodological limitations of 
previous studies into consideration, we investigated the effects of these three revascularization 
therapies on postoperative cognition. In particular, we aimed to avoid some methodological issues 
that arose in the literature by using a comprehensive neuropsychological test battery and by 
including a control group of patients with known peripheral arterial disease instead of healthy 
subjects. This study will be described in Chapter 2.    
 
In addition, perioperative embolization and levels of the biomarker S-100β will be studied 
in CEA, CASdp and CASfr procedures in patients with high-grade asymptomatic carotid artery 
stenosis or symptomatic lesions that have caused a TIA such as amaurosis fugax. Since some 
patients may experience cognitive improvement while others may have cognitive decline after 
carotid revascularization, it is important to identify those patients as this may influence the decision 
to intervene, especially in asymptomatic patients. Because of their ability to evaluate the 
differences between techniques in vivo or early after intervention, we will investigate whether 
embolization as detected by TCD and S-100β measures are able to predict postoperative cognition. 
This study will be described in Chapter 3. 
 
Finally, embolic showers may be reduced by novel techniques such as transcervical CAS 
with flow reversal.82 Because direct comparisons between CASfr, CASdp and CEA are currently 
lacking, Chapter 4 will describe a detailed analysis of the transcranial Doppler recordings during 
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these three revascularization techniques. The perioperative embolic load will be divided into three 
phases; before, during, and after cerebral protection to study the specific embologenic risk inherent 
to every phase during carotid revascularization.  
 
In Chapter 5 the results of this thesis will be summarized, compared to the literature and 
discussed. Limitations inherent to our research and future perspectives for research in this field will 
be explored.  
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Abstract 
 
Objective: It is unclear whether carotid revascularization can improve the cognitive problems often 
observed in patients with carotid stenosis. We examined the presence of preoperative disturbances 
and the effects of different types of carotid revascularization on cognition. 
 
Method: Forty-six patients treated for significant carotid stenosis [26 carotid endarterectomy 
(CEA), 10 transfemoral carotid stenting with distal filters (CASdp), and 10 transcervical stenting 
with flow reversal (CASfr)] as well as a matched control group of 26 vascular patients without 
carotid stenosis were included. Patients and controls were tested 1 day preoperatively and 1, 6, and 
12 months after surgery on 18 neuropsychological variables. 
 
Results: A significant amount of carotid patients as well as vascular controls showed cognitive 
defects at preoperative testing. None of the neuropsychological variables showed significant group 
differences between CEA, CASdp, CASfr, and controls, and only 1 revealed interaction between 
type of revascularization and improvements over time, though this effect dissolved when two 
outliers were excluded. Thirteen of 18 variables showed improved scores over time, regardless of 
the group. Compared with controls, about 10% of patients showed improvements, while 20% 
showed cognitive deterioration 6 months after revascularization.  
 
Conclusions: Results show similar effects for CEA, CASdp, and CASfr on cognition. Large 
practice effects due to repeated testing confirm the importance of using control groups in 
prospective cognition studies. Because of the small sample size, this study should be regarded as 
an exploratory study, larger studies on the cognitive consequences of carotid revascularization 
remain warranted. 
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Introduction 
 
Carotid artery stenosis has been identified as an important risk factor for stroke, with 
increasing risk depending on the severity of the stenosis 1. Furthermore, symptomatic as well as 
asymptomatic carotid stenoses have been described to be associated with cognitive disturbances.2, 
3 Silvestrini et al.4 demonstrated that unilateral left and right-sided asymptomatic carotid stenosis 
affects cognitive abilities specific to the ipsilateral hemisphere. Reduced blood flow to the brain or 
silent infarctions due to microembolization from the carotid plaque may be factors linking the 
carotid stenosis to cognitive deficits.5  
 
To reduce the risk of stroke, carotid endarterectomy (CEA) - that is, the surgical removal 
of the plaque - is classically performed and is shown to be effective in reducing stroke risk in 
patients with recent carotid territory symptoms6 as well as in asymptomatic patients.7 Since CEA 
reduces stroke risk by half in asymptomatic patients,7 CEA is carried out regularly in this 
population, although the debate whether asymptomatic patients on appropriate medical treatment 
should also be treated surgically is still ongoing.8 Transfemoral carotid stenting with distal filter 
protection (CASdp) has been suggested as an alternative for CEA, especially in high-risk patients, 
reducing cranial nerve injury, wound complications, and possible negative effects of general 
anesthesia such as myocardial infraction.9 In CASdp, a catheter is threaded up from the femoral 
vein to the carotid, where stenting and possible balloon dilatation can be performed. Although some 
studies have supported that CAS and CEA are both safe and effective methods of stroke prevention 
in appropriately selected patients and if treated by proficient surgeons or endovascular therapists,10-
12 CASdp is associated with an increased risk of new lesions on diffusion-weighted magnetic 
resonance imaging, compared with CEA.13, 14 
CAS with flow reversal (CASfr) via a direct cervical approach is a novel technique that is 
designed to provide a shorter, more direct access via the neck to deliver the stent and balloon. The 
blood flow is reversed in the treated carotid as a protective measure to ensure that emboli flow 
away instead of towards the brain.15 CASfr gained a lot of attention because manipulation in the 
aortic arch and common carotid artery is avoided and because of a reduced number of new 
diffusion-weighted magnetic resonance imaging lesions caused by emboli showers typically 
observed during stenting and dilation using distal embolic protection.15  
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Whether carotid revascularization in general has a positive, negative or no effect on 
cognition is still under discussion.16 Publications are often contradictory due to differences in 
demographics (educational level of the patient) and clinical presentation – for example, stroke 
versus transient ischemic attack (TIA), affected side and severity of the stenosis.17 Studies 
evaluating the cognitive changes after carotid treatment often have no (matched) control group, 
and the timing of assessments and type of tests used vary widely, which also plays an important 
role in the sometimes conflicting findings.17 Without an appropriate control group, the impact of 
practice effects cannot be estimated adequately. Even if there is no underlying change 
accomplished by the intervention, improved test scores may occur, since the mere familiarity with 
testing material may enhance performance. The more the control group represents the patients 
group, the better the practice effects can be estimated. Since carotid stenosis is related to cognitive 
problems, these cognitive problems could for example limit the practice effect that carotid patients 
can experience due to limited learning abilities. Alternatively, lower baseline scores may allow 
larger increases in cognitive scores. When using a control group, it is therefore important that 
patient and control group have similar baseline cognitive abilities.  
Revascularization could improve cognition by restoring the blood flow to the brain. On the 
other hand, perioperative microembolization and hypoperfusion with or without postoperative 
hyperperfusion could inflict cerebral damage and impair cognitive functions.16, 18 Furthermore, the 
jury is still out there as to whether CEA or CASdp have a similar impact on a cognitive level.16, 17, 
19 Both cognitive improvement and deterioration have been reported after either technique in 10 to 
15% of patients.17 
Studies on the cognitive outcome of CASfr by Ortega et al.20, 21 have shown promising 
cognitive results - that is, higher postoperative test scores - but in the first study there was no control 
group, while in the second study normative data were used as a control group to assess cognitive 
changes after CASfr. Despite the fact that normative data are a good way to evaluate a cognitive 
performance at one point, they will not lighten the problem of possible confounders such as practice 
effects.  
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In this study we compare the neurocognitive consequences after CEA, CASdp, CASfr 
according to a strict follow up schedule. A matched control group, comprising vascular patients 
without significant carotid stenosis (< 50%) was selected.  
 
 
Method 
 
Patients and controls 
Forty-six patients with significant internal carotid artery stenosis without ostial common 
carotid artery lesions or tandem lesions (≥ 80% for asymptomatic and 60% for symptomatic cases 
on duplex ultrasound) were included. Twenty-six were treated with CEA, 10 underwent CASdp, 
and 10 CASfr. Exclusion criteria were history of previous carotid interventions, coronary artery 
bypass grafting, or stroke within the past 2 years, age >80 years, psychiatric or neurological 
disorders, alcohol abuse, and a Mini Mental State Examination (MMSE) score lower than 24. 
Following Plessers et al.,17 to avoid any influence of recent brain damage on the possible cognitive 
changes evoked by revascularization, symptomatic patients were also excluded if they suffered 
from a recent ischemic stroke. Consequently, only symptomatic patients that had experienced a 
TIA such as amaurosis fugax were included. Twenty-six patients with peripheral arterial disease 
(PAD) were selected from the outpatient’s clinic as a matched control group using the same 
exclusion criteria. Controls were matched for sex, age, and socioeconomic status (SES). We used 
the Hollingshead’s index,22 a computed score based on education and occupation level, as a 
measurement of SES. All controls had less than 50% carotid stenosis on duplex ultrasound. The 
Ghent University Hospital ethical committee approved this prospective study and all participants 
gave written informed consent.  
 
Carotid revascularization procedures 
CEA or CAS was chosen as technique for revascularization based upon the anatomical 
characteristics and comorbidities of the patient but also taking the surgeon’s preference and 
expertise into account.  
CEA was carried out under general anesthesia using selective shunting and patch plasty. 
CAS was carried out under local anesthesia with selective predilation, mandatory stenting, and 
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selective postdilation. All CAS patients received dual antiplatelet therapy. In the transfemoral CAS 
embolic protection devices were always used, while in CAS via the neck flow reversal was created 
between the common carotid artery and contralateral common femoral vein using the 
ENROUTE™ Neuroprotection System (Silkroad Medical, Sunnyvale, CA, USA).  
 
Neuropsychological assessment 
Besides the MMSE as a dementia screening test, an extensive neuropsychological test 
battery consisting of 13 tests was used, of which 18 variables were derived (Table 1). 
Neuropsychological examinations were administered 1 day before and 1, 6, and 12 months after 
surgery and took approximately 90 to 120 min to complete. The same time intervals were used for 
the control group.  
 
Neurological evaluation 
All patients received a preoperative (1 day before surgery) and postoperative (after 1 
month) clinical neurological evaluation.  
 
Statistical analyses 
To determine preoperative cognitive difficulties, the test scores of the patients and controls 
on the first examination were compared to normative data of healthy people. These normative data 
were subdivided according to age, sex, and sometimes education level. We considered that at least 
10% of the variables should show a clinically significant impairment, so when on two of the 18 
variables a patient scored more than 2 standard deviations from his norm, or on three of the 18 
variables she or he scored more than 1.5 standard deviations, the patient was categorized as having 
a cognitive deficiency.  
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Table 1 
Cognitive domains and neuropsychological tests. 
Cognitive Domain Neuropsychological Test 
Long-term memory AVLT, Sum 
 AVLT, delayed recall 
 CFT, delayed recall 
Attention SS (forwards)  
 DS (forwards)  
 SS-C  
 D-2 
 TMT-A 
Executive functioning SS (backwards)  
 DS (backwards)  
 SCWT  
 Phonological verbal fluency, COWAT 
 Semantic verbal Fluency from the GIT 
 TMT-B 
Fine Motor Abilities Grooved Pegboard Left 
 Grooved Pegboard Right 
Spatial Functioning Judgement of Line Orientation 
 Line Bisection Task 
Note. AVLT = Auditory Verbal Learning test; CFT = Complex Figure Task; SS = Spatial Span from the Wechsler 
Memory Scale-III (WAIS-III); DS = Digit Span from the WAIS-III; SS-C = Symbol Substitution coding task from 
the WAIS-III; D-2 = d2 Test of Attention; TMT = Trail Making Test (Parts A and B); SCWT = inference factor of 
the Stroop Color and Word Test; COWAT = Controlled Oral Word Association Test (letters NAK); GIT = 
Groninger Intelligence Test. 
 
To detect significant cognitive changes over time, we used two approaches that have shown 
to be complementary.23 First, we compared the mean performance of the different revascularization 
groups and the control group over time by using mixed models analysis, allowing us to identify 
main effects of time, group, and the interaction between them for each variable. Second, we 
assessed the incidence of improvements or deteriorations over time on a subject level. Raw scores 
were rescaled so that higher scores represent better cognitive results. Next, difference scores were 
calculated for every subject: difference score = test score (after 1, 6, or 12 months) – preoperative 
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test score. Like several other studies,24, 25 z scores were calculated using the difference scores of 
the control group as a test-retest measurement error by the following formula: z = [(difference score 
patient) – (mean difference score control group)]/(standard deviation difference score control 
group). This way, the z scores represent deviations from the expected test-retest effects. The larger 
the absolute z score, the more the subject deviates from what is expected as a normal test-retest 
difference. When the z score on at least two of the 18 variables was more than 2, or on at least three 
of the 18 variables the z score was more than 1.5, the patient was categorized as either improved 
or impaired over time. Chi-square tests were performed to compare categorical variables such as 
clinical symptoms in cross tables and one-way analysis of variance (ANOVA) was used to compare 
continuous variables. Residuals for every variable showed a normal distribution. 
 
Results 
 
Demographic characteristics are displayed in Table 2. No dropouts occurred at the 1-month 
follow-up visit but due to severe illness, one CASdp was lost 6 months postoperatively. A subgroup 
consisting of 18 CEA, 5 CASdp, 4 CASfr, and 13 controls was tested at a 1-year follow-up. 
All revascularization groups and the control group had similar preoperative MMSE scores, F(3, 
71)= 0.80, p = .50. None of the patients showed new neurological symptoms except for one CEA 
patient who had cranial nerve injury and one CASdp patient who had a minor stroke in hospital. 
No deaths or myocardial infarcts occurred.  
 
Preoperative cognition 
There was no difference between patients and controls in the prevalence of cognitive 
defects, χ²(1) = 0.45, p = .50. Compared with normative data of healthy persons of the same sex, 
age, and education level, 54% and 46% of carotid patients and controls showed (preoperative) 
cognitive problems at the first testing. Within the group of carotid patients, 52% and 58% of 
patients with left or right-sided stenosis, respectively, showed preoperative cognitive defects. Thus, 
no significant influence of having left-sided stenosis or right-sided stenosis on the presence of 
preoperative cognitive abnormalities could be detected, χ²(1) = 0.12, p = .73 and χ²(1) = 0.53, p = 
.47.  
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Table 2  
Demographic characteristics. 
 
 
CEA (n = 26) CASdp (n = 10) 
 
CASfr (n = 10) Control (n = 26)  
p 
Age 68.2 (6.7) 64.8 (9.2) 70.5 (7.0) 67.3 (7.1) .36 
Sex (Male) 15 (58%) 7 (70%) 6 (60%) 17 (65%) .89 
Socioeconomic status 29.5 (14.6) 33.1 (13.2) 28 (11.3) 29.6 (12.7) .85 
Symptomatic lesion 12 (46%) 4 (40%) 2 (20%) -  .35 
# Days between 
symptoms & surgery 
40.7 (39.7) 19.3 (15.2) 60.0 (42.4) -  .42 
Left sided surgery 10 (38%) 6 (60%) 5 (50%) -  .49 
Contralateral carotid 
artery stenosis (>50%) 
10 (38%) 5 (50%) 7 (70%) -  .23 
Diabetes Mellitus 8 (31%) 4 (40%) 4 (40%) 6 (23%) .68 
Antihypertensive 
treatment 
19 (73%) 3 (30%) 5 (50%) 17 (65%) .095 
Anticholesterol treatment 
(statins) 
24 (92%) 7 (70%) 9 (90%) 23 (88%) .33 
Familial vascular risk 
factors 
20 (77%) 7 (70%) 8 (80%) 16 (62%) .33 
Values are in Mean (SD) or n (%). 
 
 
Outcome after carotid revascularization 
Mixed models analysis shows no significant group differences for any of the 18 variables. 
No interactions between time and group are observed except for one variable (the D-2 test for 
attention), F(9, 166.74) = 2.36, p = .016. When two outliers are excluded, however, this effect 
dissolves F(9, 161.69) = 1.74, p = .085. Conversely, time was an independent predictor of better 
scores for 13 out of 18 variables, regardless of the group; results are listed in Table 3. All patient 
groups (CEA, CASdp, and CASfr) and the control group showed a similar increase on these 
variables over time.  
We acknowledge that the statistical power of our analysis is rather limited due to low sample size 
and that, as a result, it would be difficult to detect a significant group difference in our sample. At 
Chapter 2 
54 
 
the same time it can be estimated from the limited differences observed in our results that we would 
for example need 386 carotid patients as well as controls to reach 80% power to find a significant 
difference (p<.05) for audio-verbal memory. Although this observation does not exclude the 
existence of a group difference when these conditions are met, it does suggest that these eventual 
differences are likely to be modest. 
 
Table 3  
Main effect of the factor time for each variable. 
Neuropsychological Test F  Df(1) Df(2) p  
TMT-A 4.59 3 169.24 .004** 
TMT-B 1.79 3 102.29 .15 
SS Forwards .82 3 174.05 .48 
SS Backwards 1.56 3 171.04 .20 
DS Forwards 1.49 3 172.55 .22 
DS Backwards 4.28 3 171.71 .006** 
SCWT  7.03 3 171.61 <.001** 
Judgement of Line Orientation 3.09 3 171.74 .028* 
SS-C 5.20 3 170.60 .002** 
AVLT, Sum 13.31 3 172.62 <.001** 
AVLT, Delayed Recall 17.18 3 172.11 <.001** 
Phonological verbal fluency 6.32 3 171.27 <.001** 
Semantic verbal fluency 8.41 3 171.58 <.001** 
CFT, Delayed Recall 8.19 3 172.90 <.001** 
D-2 21.91 3 166.79 <.001** 
Grooved Pegboard Right 2.68 3 168.91 .049* 
Grooved Pegboard Left 3.14 3 165.11 .027* 
Line Bisection Task 1.31 3 173.94 .27 
Note. TMT = Trail Making Test (Parts A and B); SS = Spatial Span; DS = Digit Span; SCWT = inference factor of 
the Stroop Color and Word Test; SS-C = Symbol Substitution coding task; AVLT = Auditory Verbal Learning test; 
CFT = Complex Figure Task; D-2 = d2 Test of Attention. 
* p<.05; ** p<.01. Mixed-models analysis  
 
On a subject level at 1 month, five patients (11%) and three controls (12%) showed 
cognitive deterioration while two patients (4%) and five controls (19%) showed improvement. 
Prospective comparison of cognitive effects 
55 
 
These differences were not significant χ²(2) = 4.30, p = .12. At 6 months, 10 patients (22%) and 
one control (4%) showed deterioration while four patients (9%) and one control (4%) showed 
improvement. This difference, however, failed to reach significance, χ²(2) = 5.15, p = .076. The 
subgroup of carotid patients and controls who received cognitive testing at 12 months showed 
similar improvements and impairments with the testing at 6 months.  
 
Discussion 
 
Preoperative cognition 
Symptomatic and asymptomatic carotid stenosis may be associated with existing cognitive 
impairments.2, 3 Our results show that not only patients with significant carotid artery stenosis, but 
also patients with PAD appear to have cognitive deficits at baseline.  
This may reflect that patients with similar risk factors such as diabetes, hypertension, 
hypercholesterolemia, current smoking, and so on, and proven PAD but without carotid artery 
disease may suffer from similar cognitive deficits.3 
 
Outcome after carotid revascularization 
Our study unveils no clear influence of the type of carotid revascularization on 
postoperative cognitive functioning. None of the 18 variables showed a significant group 
difference, and only one showed a small interaction effect. The fact that CEA and CASdp have 
similar effects on cognition is in agreement with previous research.17, 19 We now showed that also 
direct access using flow reversal does not lead to any significant cognitive changes compared with 
other techniques. 
Because all groups, even the control group, scored significantly better on 13 of 18 variables 
over time, our results demonstrate a clear practice effect due to repeated neurocognitive testing. 
Even though, where applicable, alternative test versions were used, patients as well as controls 
became test wise. This shows the necessity of including a control group to take these practice 
effects into account. Repeatedly testing participants can result in higher cognitive scores, regardless 
of underlying cognitive changes.  
Since the different types of revascularization do not yield clear cognitive differences, 
decisions on whether to perform one of the types of carotid revascularization seem to be better 
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based on primary endpoints like stroke, myocardial infarct, and other secondary endpoints, rather 
than on cognitive functioning. Although it is clear that CASdp is associated with higher 
perioperative embolization and magnetic resonance imaging lesions,26, 27 these measures seem not 
be linked to worse cognitive outcome.17, 28 
 
Based on our findings, advocating surgery for asymptomatic carotid stenosis solely to 
alleviate existing cognitive difficulties seems not justified, as patient groups do not appear to 
benefit from surgery when compared to vascular controls. This is in contradiction with a recent 
study showing that untreated patients with significant carotid stenosis have worse cognitive scores 
over time than treated patients,29 so further research is certainly warranted. On a subject level, at 1 
month, there are no clear differences between patients and controls, but after 6 months, a marginally 
significant difference seems to be present. Of the patients who received carotid revascularization, 
9% and 22% showed cognitive improvements or impairments respectively, which is in good 
agreement with other studies.9, 17, 28 It appears that carotid revascularization is beneficial for some 
patients while others do not seem to benefit from it in the long term. Previous research showed that 
the cognitive improvements that small groups of patients gain from revascularization seem 
associated with the recovery of abnormal cerebral perfusion.30, 31 Cognitive deterioration has, on 
the contrary, been linked to postoperative hyperperfusion.32, 33  
 
The inclusion of a control group allowed us to take practice effects into account. Moreover, 
our control group consisted of patients with PAD, who are more comparable to patients with carotid 
artery disease than healthy controls. A longer follow-up period was implemented to discriminate 
between short-term and long-term effects. We encourage researchers to include a long-term follow-
up when evaluating cognitive changes after carotid revascularization, because the long-term results 
are more clinically relevant for the patients. While the measurement at 1 month and 6 months 
differed, the 12-month measurement was comparable to the testing at 6 months. We do not believe 
that differences in local versus general anesthesia had an effect on any of our results, since previous 
research34 showed there is an effect of general anesthesia on cognition on the first postoperative 
day, but after six days this difference between local and general anesthesia already dissolves. 
Furthermore we used a comprehensive neuropsychological test battery. The study did not rely on 
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short screenings instruments such as the MMSE which are considered insufficient.3, 17 Finally, we 
had a very low dropout at 1 and 6 months, preventing possible subgroup confounders.  
 
Limitations of our study are the small sample size in the stenting groups and the 
nonrandomized design. Two recent systematic reviews concluded that most studies comparing 
CEA and CASdp do not show cognitive differences.17, 19 Our finding that CASfr shows no 
cognitive differences compared to the other revascularization types corroborates with these 
findings. It is, however, possible that larger studies may be able to find small cognitive differences, 
therefore our study should be considered as an exploratory study. To further elucidate the influence 
of revascularization on cognition, a larger study comparing different types of revascularization with 
a control group consisting of asymptomatic carotid patients on best medical treatment is 
recommended. This would allow us to study the long-term effects on a cognitive level of 
intervention versus medical treatment only. Further elucidating the relationship between cognitive 
changes and changes in cerebral perfusion using single-photon emission computed tomography 
(SPECT) is also a promising research topic. Ideally, deciding on advising revascularization could 
also depend on the expected cognitive effects for each patient. 
 
In conclusion, we did not find significant differences between CEA, CASdp, and CASfr on 
cognition. All groups, including the control group, showed similar increases in test scores over 
time, attributable to practice effects. One month after surgery, results are mixed, but in the long 
term, around 10% of patients seem to benefit from revascularization, while around 20% show 
significantly lower scores. Larger studies comparing the different types of carotid revascularization 
remain warranted. 
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Abstract 
 
Background: Cognitive changes after carotid revascularization have been reported in 10-20% of 
patients. The aetiology of cognitive impairments remains largely unknown. This study evaluates 
the predictive value of S-100β serum values and perioperative micro-embolization on cognition 
after carotid revascularization. 
 
Methods: Forty-six patients with significant carotid stenosis underwent carotid endarterectomy 
(CEA, n=26), transfemoral carotid artery stenting with distal protection (CASdp, n=10) or 
transcervical carotid stenting with dynamic flow reversal (CASfr, n=10). Twenty-six matched 
vascular patients without carotid stenosis were recruited as controls. All patients underwent 
comprehensive cognitive testing on the day before and one month after carotid revascularization. 
S-100β analysis was performed in 31 cases pre-, peri-, and 2, 6, and 24 hours after carotid surgery, 
and in 25 patients transcranial Doppler (TCD) monitoring was done during surgery. 
 
Results: In the three treatment groups similar transient increases in S-100β values were observed. 
CASdp was associated with a higher embolic load than CEA and CASfr, while CEA was also 
associated with less micro-embolization than CASfr. Cognitive improvement or deterioration could 
not be predicted by S-100β or perioperative embolic load for any of the investigated cognitive 
domains.  
 
Conclusions: Cognitive deterioration could not be predicted using perioperative embolic load and 
S-100β changes. A similar inverted u-curve of the S-100β levels was observed in the three groups 
and may be caused by impairment in the blood-brain barrier during intervention, and not due to 
cerebral infarction. Distal protection CAS is associated with a higher embolic load than 
transcervical CAS using dynamic flow reversal and CEA, but the long-term impact of this higher 
embolic load is yet unknown. Perfusion related measures seem promising in their ability to predict 
cognitive decline. 
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Introduction 
To reduce the stroke risk in patients with significant carotid artery stenosis, carotid 
endarterectomy (CEA) and carotid artery stenting (CAS) are performed.1, 2 Many studies have 
shown that CAS with distal protection filters (CASdp) is associated with higher stroke rates and 
incidence of postoperative lesions on diffusion-weighted magnetic resonance imaging (DW-
MRI).3 In an effort to reduce these higher stroke and new DW-MRI lesion rates, proximal 
protection is increasingly used.4, 5 Transcervical CAS with dynamic flow reversal (CASfr) has been 
shown to be safe with a low stroke, death, and myocardial infarction rate.6, 7 Furthermore it is 
associated with a reduced number of new DW-MRI lesions compared to transfemoral CAS with 
distal protection devices (CASdp).6, 7 Manipulation in the aortic arch and origin of the common 
carotid is avoided and ideally during flow reversal emboli should theoretically not be able to 
damage the brain.7   
 
Besides a focus on stroke and other primary outcome measures, as Siddiqui and Hopkins8 
stated, it is important to assess the cognitive effects of carotid revascularization, as even 
asymptomatic patients may sometimes benefit from revascularization. Indeed, recent studies9-11 
reported improvements for some patients, while other patients showed cognitive declines. On the 
one hand, carotid revascularization may improve the blood flow to the brain and hence result in 
cognitive improvement. On the other hand, perioperative micro-embolization and hypoperfusion, 
and postoperative hyperperfusion may cause cognitive decline.11, 12 To date, it is unclear how these 
factors interact. In this study, we will focus on possible factors predicting negative cognitive 
outcome, such as perioperative embolization load and indicators of ischemic brain damage.   
 
To study perioperative embolization during carotid revascularization, transcranial Doppler 
ultrasonography (TCD) is an effective tool.13 Larger embolic loads for CASdp have been observed 
in comparison with CEA.14-16 Although Ribo et al.17 revealed that CASfr is able to reduce emboli 
showers typically observed during stent deployment, direct comparisons of transcervical CASfr 
with CASdp and CEA have not been published. It is important to examine perioperative 
embolization as it has shown to be linked with new DW-MRI lesions post intervention.18 
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A sensitive marker of cerebral injury and blood–brain barrier dysfunction19-21 is the 
neuroprotein S-100β. S-100β rises in patients with focal brain damage after ischemic territorial 
MCA infarction,19 which makes this biomarker especially relevant to study cerebral damage after 
carotid revascularization because the MCA arises from the internal carotid. Studies connecting S-
100β to perioperative embolization assessed by TCD reported conflicting results.22, 23 S-100β 
shows maximum levels most often within 24 hours after cardiac surgery,24 has a biological half-
life of approximately 25 minutes, and is rapidly excreted by the kidney.25 
 
The factors that may lead to cognitive deterioration after carotid treatment have not been 
clearly identified. This study will directly compare perioperative embolization load and S-100β 
levels after CEA, CASdp, or CASfr. Furthermore, the effect of perioperative embolic load and S-
100β serum level changes on cognitive changes will be investigated.  
  
Material and Methods 
Patients and controls 
Between February 2011 and January 2014, 46 patients with significant internal carotid 
artery stenosis without ostial common carotid artery lesions or tandem lesions (≥ 80% for 
asymptomatic and ≥ 60% for symptomatic lesions on duplex ultrasound) were included of which 
26 underwent CEA, 10 CASdp, and 10 CASfr. Exclusion criteria were history of previous carotid 
interventions, CABG, or stroke within the past 2 years, age >80 years, psychiatric or neurological 
disorders, alcohol abuse, and a Mini Mental State Examination (MMSE) score lower than 24.  
To avoid any influence of recent brain damage on the possible cognitive changes evoked 
by revascularization, symptomatic patients were also excluded if they suffered from a recent acute 
stroke.9 So only symptomatic patients who experienced a transient ischemic attack (TIA) such as 
amaurosis fugax were included. Twenty-six patients with peripheral arterial disease (PAD) were 
selected from the vascular outpatient’s clinic as a matched control group using the same exclusion 
criteria. Controls were matched for sex, age, and socio-economic status (SES). The Hollingshead’s 
index,26 a computed score based on education and occupation level, was used as a measurement of 
SES. All controls had less than 50% carotid stenosis on duplex ultrasound. All 46 carotid patients 
participated in the cognitive study. Of these, only 31 patients had S-100β evaluation, and 25 
patients received TCD monitoring due to logistical reasons or a poor transtemporal insonation 
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window for TCD in some patients.27 Twenty-one carotid patients had S-100β, TCD monitoring as 
well as the cognitive assessment. The control group solely underwent cognitive testing. The Ghent 
University Hospital ethical committee approved this prospective study and all participants gave 
written informed consent.  
 
Carotid revascularization procedures 
The choice between CEA or CAS was based on the individual and anatomical 
characteristics, comorbidities of the patient, and the patient’s preference. The decision was made 
by a multi-disciplinary team taking into account the international guidelines.28 CEA was routinely 
carried out under general anesthesia using selective shunting and Dacron patch plasty. CAS was 
carried out under local anesthesia with selective predilation, mandatory stenting and selective 
postdilation. All CAS patients received dual antiplatelet therapy (aspirin and clopidogrel). In 
transfemoral CAS distal filter embolic protection was always used, while in transcervical CAS 
dynamic flow reversal was created between the common carotid artery and contralateral common 
femoral vein using the ENROUTE™ Neuroprotection System (Silkroad medical, Sunnyvale, CA, 
USA).  
 
Neuropsychological assessment 
Besides the MMSE as a dementia-screening test, a neuropsychological test battery 
consisting of 13 tests was used out of which 18 variables were derived. These variables were 
allocated to their respective cognitive domain: attention, long-term memory, executive functioning, 
fine motor abilities, or visuospatial functioning (see Table II in Plessers et al.10 for more 
information about the specific neuropsychological tests). Neuropsychological examinations were 
performed by M.P. 1 day before and 1 month after surgery and took approximately 90 to 120 
minutes to complete. Identical time intervals were used for the control group.  
 
Transcranial Doppler 
Perioperative TCD monitoring was performed unilaterally using a commercially available 
TCD system (DWL Doppler-BoxTM, Compumedics Germany GmbH, Germany). A 2-MHz 
transducer was placed over the ipsilateral temporal skull window before the start of the carotid 
surgery and recordings of the intervention were made from incision until closure.  
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Emboli were counted manually according to consensus statements.13 Only unidirectional 
High-Intensity Transient Signals (HITS - less than 300 ms) at least 7dB higher than that of the 
background signal with a distinctive ‘chirp’, ‘snap’ or ‘moan’ sound were recorded as emboli.13, 22 
Because fluid-filled syringes always contains small air bubbles, even after thorough desufflation29 
and these small air bubbles are of low clinical value, embolic signals directly related to the injection 
of contrast fluid were discarded. A global TCD-score with one second of emboli showers or 
curtains counting as 10 separate emboli was computed as done previously by Brightwell et al.22 As 
such, we obtained a mean global embolic score that is comparable for the three types of surgery.  
 
Serum S-100β biomarker 
Blood samples were collected immediately before carotid surgery, after declamping or 
retrieval of the embolic protection device, and 2, 6, and 24 hours post intervention. Blood samples 
were centrifuged at 1500 rpm for 15 minutes at 20°C. The resulting serum was stored in in multiple 
aliquots at -25°C. Serum levels of S-100β were determined using an automatic 
electrochemiluminescence assay (S100 Cobas®) with a measuring range of 0.005 – 39 µg/L. The 
median value and 95th percentile for healthy adults is 0.046 and 0.105 µg/L respectively. The 
biochemist responsible for carrying out these analyses was blinded to the revascularization group 
and TCD data. 
 
Neurological evaluation 
All patients received a preoperative (1 day before surgery) and postoperative (after 1 
month) clinical neurological evaluation by one of the authors (D.H.).  
 
Statistical analyses 
Raw cognitive scores were rescaled so that higher scores represent better cognitive results. 
Next, difference scores were calculated for every subject: difference score = test score after 1 month 
– preoperative test score. Like several other studies,30, 31 z-scores were calculated using the 
difference scores of the control group as a test-retest measurement error by the following formula: 
“z-score = (difference score patient – mean difference score control group) / standard deviation 
difference score control group”. This way, the z-scores represent deviations from the expected test-
retest effects. The larger the absolute z-score, the more the subject deviates from what is expected 
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as a normal test-retest difference. Thus, the control group data were used to estimate the practice 
effect. Domain z-scores were the calculated mean of the relevant variables and represent the mean 
change of a cognitive domain when compared with the mean change of the control group.  
Linear regression analysis was used to assess the predictive value of S-100β and TCD 
perioperative embolization on the five cognitive domain scores for all carotid patients. Chi-square 
tests were performed to compare categorical variables such as clinical symptoms in cross tables 
and one-way ANOVA was used to compare continuous variables, such as embolic load. Changes 
over time and between patient groups for S-100β was examined with repeated measures ANOVA 
with Huyn-Feldt correction. Residuals for every variable showed a normal distribution. 
 
Results 
Demographic characteristics are displayed in Table I. All revascularization groups and the 
control group had similar preoperative MMSE scores, F(3,71)=.80, p=.50. Most patients 
experienced no neurological symptoms post intervention except for one CEA patient who had a 
cranial nerve injury and one CASdp patient who suffered from a minor stroke in-hospital. No death 
or myocardial infarct occurred and no patients were lost for follow up. 
 
Since S-100β levels showed the highest mean peak value 2 hours after surgery, this value 
was used in further analysis. None of the cognitive changes in long-term memory, attention, 
executive functioning, fine motor abilities, and visuospatial functioning could be predicted using 
S-100β or the TCD micro-embolic load for the whole group of carotid patients (Table II).  
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Table I. Demographic characteristics. 
 
 
CEA (n = 26) CASdp (n = 10) 
 
CASfr (n = 10) Control (n = 26)  
p 
Age 68.2 (6.7) 64.8 (9.2) 70.5 (7.0) 67.3 (7.1) .36 
Sex (Male) 15 (58%) 7 (70%) 6 (60%) 17 (65%) .89 
Socioeconomic status 29.5 (14.6) 33.1 (13.2) 28 (11.3) 29.6 (12.7) .85 
Symptomatic lesion 12 (46%) 4 (40%) 2 (20%) -  .35 
# Days between 
symptoms & surgery 
40.7 (39.7) 19.3 (15.2) 60.0 (42.4) -  .42 
Left sided surgery 10 (38%) 6 (60%) 5 (50%) -  .49 
Contralateral carotid 
artery stenosis (>50%) 
10 (38%) 5 (50%) 7 (70%) -  .23 
Diabetes Mellitus 8 (31%) 4 (40%) 4 (40%) 6 (23%) .68 
Antihypertensive 
treatment 
19 (73%) 3 (30%) 5 (50%) 17 (65%) .095 
Anticholesterol treatment 
(statins) 
24 (92%) 7 (70%) 9 (90%) 23 (88%) .33 
Familial vascular risk 
factors 
20 (77%) 7 (70%) 8 (80%) 16 (62%) .33 
Values are in Mean (SD) or n (%). 
  
 
Table II. Linear regression analysis of the five cognitive domains with S-100β and embolic load as 
predictors. 
Cognitive Domain F  df1, df2 p 
Long-term memory 2.31 3 , 19 .12 
Attention .62 3 , 19 .61 
Executive functioning .82 3 , 19 .50 
Fine motor abilities .54 3 , 19 .66 
Visuospatial functioning 1.04 3 , 19 .40 
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However, a significant difference between the treatment groups for perioperative 
embolization was observed, F(2,24)=55.91, p<.001. CASdp (M=584) was associated with a 
significant higher embolic load than CEA (M=62, p<.001) and CASfr (M=184, p<.001) and CEA 
was also associated with fewer emboli than CASfr (p=.02; Figure I).  
 
 
Figure I. Mean sum of perioperative emboli for each patient group. 
 
Since the last measurement of S-100β (24h post surgery) was missing in some patients (n= 
5) and the acute effect of the surgery on S-100β at 24 hours had already dissolved, we decided to 
perform the repeated measures test only on the four first measurements to avoid list wise deletion 
of cases and a subsequently lower statistical power. There was an expected transient increase of 
the S-100β level in every group, F(2.45,56.43)=30.97, p<.001, but no significant group differences 
F(2,23)=.69, p=.51 or interactions F=(4.91,56.43)=1.55, p=.19, could be detected (Figure II). 
There was no correlation between the amount of perioperative emboli and rise of S-100β, r=-.18, 
p=.44 
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figure II. Serum S-100B (µg/L) values over time for all patient groups. 
 
Discussion  
CEA, CASdp, and CASfr resulted in a similar cognitive evolution, around 10-20% of 
patients shows either cognitive improvement or deterioration after revascularization (see Plessers 
et al.10). None of the changes in the five cognitive domains could be predicted using S-100β serum 
levels and perioperative embolic load. It appears to be difficult to predict which patients will show 
postoperative cognitive decline. Many studies trying to find a relationship between S-100β and 
cognition after carotid revascularization failed to find an association32-35 and it was concluded that 
the predictive value of S-100β on cognition is inconclusive.20 The transient increase in S-100β early 
after CASdp and especially CEA has been noted in several studies, and is most often regarded as 
a consequence of an impaired blood-brain barrier caused by balloon dilation or clamping rather 
than the consequence of brain damage.35-39 Indeed, the fact that a correlation between S-100β and 
embolic load could not be demonstrated in this study, seems to implicate that S-100β may not be 
an ideal measure for cerebral infarction after carotid revascularization, but actually represents 
changes in the blood-brain barrier.35-39 We did not find a group difference between CEA, CASdp, 
and CASfr on S-100β, which confirms the findings of Brightwell et al.22 who compared CEA with 
CASdp.  
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In contrast, TCD analysis unveils significant differences in perioperative embolic load 
between the treatment modalities. Previous studies14-16 have shown that CASdp is associated with 
a higher embolic burden than CEA. Furthermore, this study shows that CASfr causes less 
embolization than CASdp. It appears that direct carotid access and dynamic flow reversal protects 
the brain better against micro-embolization than transfemoral carotid stenting with distal 
protection. This study confirms that distal filters do not always result in a reduction of perioperative 
micro-embolization.40 Direct carotid access avoids any manipulation in the aortic arch while flow 
reversal is possibly more effective because protection is in place prior to crossing the lesion.7 
Furthermore, the protected phase (i.e. the flow reversal) allows theoretically zero embolization.7 
The low embolization rate during CEA can however not yet be achieved with CASfr. 
The detected embolic load did not predict cognitive decline after surgery, as also found by 
other studies.15, 41, 42 Probably other factors such as embolic size and type (gaseous versus 
particulate) are more important than the mere number of emboli, i.e. larger and particulate emboli 
are expected to have a worse outcome than small and gaseous emboli.9 Up until now, current 
technology allows no valid differentiation between gaseous and particulate emboli.43, 44 
Technological advances may have the potential to further improve the clinical relevance of TCD 
monitoring.  
 
This exploratory study illustrates that it is difficult to predict postoperative cognitive 
deterioration, even when combining different data sets such as perioperative embolization and S-
100β. It appears that cognitive evolution after revascularization is unpredictable.41 Indeed, recent 
studies and systematic reviews point out that the vast majority of studies that have attempted to 
correlate cognitive changes with the amount and size of new DW-MRI ischemic lesions after 
revascularization have failed to find this association.9, 45 Most of these lesions appear silent. In 
contrast, research has described that restoring a preoperative low blood flow in MCA is associated 
with improved cognition following intervention,46-49 while postoperative hyperperfusion is linked 
with cognitive decline.50-52 It seems that embolization, DW-MRI and S-100β remain unable to 
predict cognitive changes so far, while measures focusing on perfusion, may be the key to 
successfully detect patients at risk for cognitive decline or patients who are likely to benefit from 
carotid revascularization.46-53 
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Although our study is limited due to a small sample size and the lack of brain MRI data, we can 
conclude that if there is an effect of perioperative embolization and S-100β on cognition, this effect 
is not very robust. Other studies have often failed to find associations between these measures and 
cognition in CEA and CASdp15, 32, 33, 41, 42 and the combination of these measures does also not 
appear to predict cognitive deterioration as shown in this study. The strength of this study is that 
differences in S-100β serum levels and perioperative embolization between CEA, CASdp, and 
CASfr have been studied including its effect on cognitive alterations using a comprehensive 
neuropsychological test battery. Our study did not rely on short screenings instruments such as the 
MMSE, which are considered insufficient.9, 54 Finally, we had no drop-outs at 1 month, preventing 
possible subgroup confounders.  
 
Conclusion  
In conclusion, this study shows no clear influence of S-100β serum levels and perioperative 
embolization on cognitive changes after carotid revascularization. CEA, CASdp, and CASfr show 
a similar inverted u-curve in S-100β values. CASdp is associated with a higher embolization rate 
in comparison with CEA and CASfr, while CEA is associated with fewer emboli than CASfr. 
Further research remains warranted. 
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Abstract 
 
Purpose: To evaluate a series of patients treated electively with carotid endarterectomy (CEA), 
transfemoral carotid artery stenting with distal filter protection (CASdp), and transcervical carotid 
stenting with dynamic flow reversal (CASfr) monitored continuously with Transcranial Doppler 
(TCD) during the procedure to detect intraoperative embolization rates.   
 
Methods: Thirty-four patients (mean age 67.6 years; 24 men) with significant carotid stenosis 
underwent successful TCD monitoring during the revascularization procedure (10 CEA, 8 CASdp, 
and 16 CASfr). Ipsilateral microembolic signals were segregated into 3 phases: preprotection (until 
internal carotid artery cross-shunted or clamped if no shunt was used, filter deployed, or flow 
reversal established), protection (until clamp/shunt was removed, filter retrieved, or antegrade flow 
re-established), and postprotection (after clamp/shunt or filter removal or restoration of normal 
flow) 
 
Results: CASdp showed higher embolization rates than CEA or CASfr in the preprotection phase 
(p<0.001). In the protection phase, CASdp was again associated with more embolization compared 
with CEA and CASfr (p<0.001). In the postprotection phase, no differences between the 
revascularization therapies were observed. CASfr and CEA did not show significant differences in 
intraoperative embolization during any of the phases.  
 
Conclusion: Transcranial Doppler recordings demonstrated a significant reduction in embolization 
to the brain during transcervical carotid artery stent placement with the use of dynamic flow 
reversal compared to transfemoral CAS using distal filters. No significant differences in 
microembolization could be detected between CEA and CASfr. The observed lower embolization 
rates and lack of adverse events suggest that transcervical CAS with dynamic flow reversal is a 
promising technique and may be the preferred method when performing CAS.  
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Introduction 
To reduce the stroke risk in patients with significant carotid stenosis, carotid 
endarterectomy (CEA) and carotid artery stenting (CAS) are both used as revascularization 
strategies.1,2 However, many studies have shown that CAS with distal protection filters (CASdp) 
is associated with higher incidences of stroke and postoperative lesions on diffusion-weighted 
magnetic resonance imaging (DW-MRI).3 Proximal protection is increasingly being used to reduce 
these rates.4,5 Transcervical CAS with dynamic flow reversal (CASfr) has the additional advantage 
of avoiding manipulations in the arch and has been associated with low stroke and death rates and 
significantly fewer new DW-MRI lesions compared to CASdp.6,7 As manipulation within the aortic 
arch and origin of the common carotid artery (CCA) is avoided and angioplasty is performed during 
flow reversal, emboli should not be able to flow to the brain.6,8  
 Transcranial Doppler (TCD) monitoring is a noninvasive technique that records the 
ultrasound echoes generated by blood flow in the cerebral arteries.9 TCD of the middle cerebral 
artery (MCA) is an effective tool when studying intraoperative embolization during carotid 
revascularization.10 In agreement with its higher prevalence of new DW-MRI lesions, CASdp has 
consistently demonstrated a greater embolic load than CEA on TCD.11-13 Although CASfr is 
capable of reducing the embolic showers that are typically observed in embologenic phases of 
CASdp, such as stenting and balloon dilation,14 no direct comparison has yet been performed 
between CASfr and the other common revascularization procedures as regard their effects on 
embolization. To this end, this study examines intraoperative embolization detected by TCD during 
CEA, CASdp, and CASfr. The microembolic signals were analyzed during the different phases of 
the procedure to assess the embolic risk inherent to each surgical phase.  
 
Methods 
Patient Sample 
Of the 48 patients with significant internal carotid artery stenosis (≥80% for asymptomatic 
and 60% for symptomatic cases on duplex ultrasound) and no ostial CCA or tandem lesions 
enrolled in this study, TCD could not be performed in 14 patients due to practical difficulties or an 
inadequate transtemporal insonation window, mostly in older women.15,16 Thus, the analysis 
focuses on 34 patients (mean age 67.6 years; 24 men) who were monitored with TCD throughout 
the entire carotid revascularization procedure (10 CEA, 8 CASdp, and 16 CASfr). The Ghent 
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University Hospital Ethical Committee approved this study, and all participants gave written 
informed consent.  
 
Carotid Revascularization  
The operator’s choice of CEA or CAS was based on anatomical characteristics and patient 
comorbidities. CEA was always carried out under general anesthesia using selective shunting and 
Dacron patchplasty. CAS was carried out under local anesthesia with selective predilation, 
mandatory stenting, and selective postdilation. CAS patients were on dual antiplatelet therapy 
before and after treatment. In transfemoral CAS, the same distal filter embolic protection was 
always used (Emboshield; Abbott Vascular, Redwood City, CA, USA), while in transcervical CAS, 
dynamic flow reversal was created between the CCA and the contralateral common femoral vein 
using the ENROUTE Neuroprotection System (Silkroad Medical, Sunnyvale, CA, USA). The 
technique of transcervical stenting with flow reversal has been previously described in detail.17 All 
patients were clinically evaluated by a neurologist the day before surgery and after 1 month.  
 
Transcranial Doppler Ultrasonography 
Intraoperative TCD monitoring was performed unilaterally using a commercially available 
TCD system (DWL Doppler-Box; Compumedics Germany GmbH, Singen, Germany). A 2-MHz 
transducer was placed over the ipsilateral temporal window before the start of surgery. Following 
identification of the ipsilateral MCA, recordings during the intervention were made from incision 
until closure, and several markers were included to indicate critical phases in the surgery (ie, 
clamping, contrast injection, balloon dilation, stenting, etc).  
 Embolic signals were defined as unidirectional peaks >7 decibels lasting <300 ms within 
the recording. Emboli were detected according to consensus criteria10 and were typically associated 
with a characteristic “chirp,” “snap,” or “moan” sound. The occurrence of emboli was segregated 
in 3 major phases (1) preprotection: before clamping, deployment of the distal filter, or flow 
reversal; (2) protection: during shunting, flow reversal, or with the filter in situ; and (3) 
postprotection: from restoration of normal flow by removal of the clamp, cessation of flow reversal, 
or filter retrieval until application of the bandage. 
 When there was a high concentration of emboli and it became impossible to differentiate 
between the separate emboli, the duration of these “embolic showers” was recorded. For each 
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surgical phase, a discrete emboli count was also calculated. Micelles of contrast fluid can evoke 
embolic-like signals on TCD.18 Furthermore, fluid-filled syringes always contain small air bubbles, 
even after thorough venting.19 Since these small air bubbles are of low clinical value, embolic 
signals directly related to the injection of contrast fluid were discarded.  
 To ensure high reliability of the TCD analysis, a random sample of 6 cases was analyzed 
independently by 2 authors (N.P., E.M.L.C) in a different laboratory using in-house software 
developed in MATLAB based on the same detection consensus criteria.10 Embolic signals from 
these patients were also divided according to the 3 phases (preprotection, protection, 
postprotection).  
 
Table 1. Demographic, Clinical, and Procedure Characteristics.a 
 CEA (n=10) CASdp (n=8) CASfr (n=16) p 
Age, y 65.7±4.3  62.4±9.9 71.3±9.5 0.048 
Men 6  5  13  0.43 
Diabetes  3  4  5  0.61 
Antihypertensive agents  6  3  11 0.32 
Statin therapy 10  6  15  0.16 
Symptomatic lesion 6  4  8  0.87 
Time between symptoms and surgery, d  37.5±38.7 20.5±17.5 59.9±57.1 0.37 
Procedure time, minb 101.9±17.3 40.5±8.8 76.5±20.7 — 
Protection time, minc 30.0±6.1 9.7±1.8 12.6±7.3 — 
General anesthesia 10  1 4  — 
Abbreviations: CASdp, carotid artery stenting with distal protection filters; CASfr, transcervical carotid artery 
stenting with dynamic flow reversal; CEA, carotid endarterectomy. 
aContinuous data are presented as the means ± standard deviation; categorical data are given as the counts. 
bTime from incision until end of closure. 
cShunt, filter, or flow reversal time. 
 
Statistical Analyses 
Between-group differences throughout the procedure were assessed with repeated measures 
analysis of variance (ANOVA). Chi-square tests were performed to compare categorical variables 
(eg, clinical symptoms) in cross tables, and one-way ANOVA was used to compare normally 
distributed continuous variables (eg, the number of emboli and duration of embolic showers). Post-
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hoc tests were performed with a Bonferroni correction. Inter-rater agreement was assessed by 
calculating the Pearson product moment correlation coefficient. Statistical analyses were 
performed using the Statistical Package for the Social Sciences (SPSS; version 22; SPSS, Inc., 
Chicago, IL, USA).  
 
Results  
Apart from an unexpected difference in age, the 3 groups displayed no significant 
differences in demographic or disease characteristics (Table 1). Intervention characteristics are also 
shown in Table 1. All revascularization procedures were technically successful (<30% residual 
stenosis). One CASdp patient had a minor in-hospital stroke and a CEA patient suffered cranial 
nerve injury, but no death occurred post intervention. Two patients in the flow reversal group 
developed an iatrogenic CCA dissection. The first occurred upon introduction of the arterial sheath, 
probably owing to the learning curve. In the second case, the Rummel loop was used as a tourniquet 
to stop inflow, but despite careful manipulation, the heavily calcified CCA was dissected. An 
additional stent was placed via the transfemoral route in each CCA. 
 The most embolization occurred in the protected phase for CASdp and CASfr, while the 
highest embolization rates during CEA were observed in the postprotection phase (Figure 1). 
Throughout the procedure, large between-group differences were detected for the number of 
emboli as well as seconds of embolic showers (F2,31=57.91, p<0.001, ηp2=0.79 and F2,31=14.37, 
p<0.001, ηp2=0.48, respectively). For both variables, CASdp showed a higher frequency of emboli 
compared with CEA or CASfr (p<0.001), while no significant differences could be detected 
between CEA and CASfr (p=0.486 and p=0.493 for emboli and showers, respectively; Figure 1). 
 During the preprotection phase, no differences were detected between the interventions for 
the total duration of showers (F2,33=2.34, p=0.113, ηp2=0.13), but there was a significant 
difference in the number of discrete particulate emboli (F2,33=35.00, p<0.001, ηp2=0.69). CASdp 
generated more discrete emboli than CASfr (p<0.001) and CEA (p<0.001). No differences could 
be detected between CEA and CASfr (p=0.177). 
 During the protection phase, significant differences for embolic showers and discrete 
emboli were observed (F2,33=30.02, p<0.001, ηp2=0.66 and F2,33=59.12, p<0.001, ηp2=0.79, 
respectively). For both variables, CASdp differed significantly from CEA and CASfr (p<0.001), 
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but no differences were detected between CEA and CASfr for discrete emboli or embolic showers 
(p=0.424 and p=0.296, respectively). 
 In the postprotection phase, all techniques showed a similar incidence of embolic showers 
and discrete emboli (F2,33=0.33, p=0.719, ηp2=0.02 and F2,33=0.27, p=0.769, ηp2=0.02, 
respectively). 
 Inter-rater analysis showed excellent correlations for the discrete emboli [r=0.994, p<0.001 
(n=18)], as well as for the embolic showers [r=0.917, p<0.001 (n=18)].  
 
 
Figure 1. (A) Mean number of discrete emboli for each group in each phase. (B) Mean duration of 
embolic showers for each group in each phase.  
 
Discussion  
As in other studies,11,12 our investigation found that filter-protected transfemoral CAS was 
associated with a significantly higher embolic load compared with CEA throughout the procedure. 
This study, however, also showed that transcervical CAS with dynamic flow reversal was 
associated with fewer emboli than filter-protected CAS and yielded embolization rates comparable 
to those of CEA.  
 When looking in detail at which phases of the intervention are responsible for these 
differences, it appears that CASfr and CEA already show less embolization in the preprotection 
phase before the EPD, shunt, or flow reversal are in place. This can be explained by the fact that 
CEA and CASfr with a direct cervical approach are able to treat the lesion site directly, while in 
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CASdp, manipulation in the aortic arch and the origin of the CCA may dislodge emboli that migrate 
to the brain. This is in line with other studies suggesting that contralateral DW-MRI lesions after 
CASdp3,7,20 are most likely caused during the preprotection phase before entering the CCA. The 
study of Leal et al.7 showed no contralateral hemispheric infarcts in CASfr patients, while 2 of 11 
new DW-MRI lesions detected in CASdp patients were contralateral. Gupta et al.11 failed to find a 
significant difference between CASdp and transfemoral CAS with flow reversal in the 
preprotection phase, indicating the importance of transcervical access to avoid early embolization. 
The duration of embolic showers did not reveal any differences in the preprotection phase because 
these showers are very infrequent before manipulating the lesion site. 
 During stenting and angioplasty, CASdp shows a higher frequency of discrete emboli as 
well as embolic showers. In many cases, the dynamic flow reversal eliminates embolization during 
stenting and angioplasty completely, as also reported by Ribo et al.14 and Flores et al.8 Although 
distal protection filters are designed to reduce intraoperative embolization, some studies have found 
them to be associated with an even higher incidence of microembolization than unprotected 
stenting.8,21,22 Furthermore, the beneficial effects of the EPD on reducing new DW-MRI lesions 
are not observed universally.3,23,24 
 There are several explanations why distal embolic protection filters may not be able to 
protect the brain. Macroemboli are propelled into the filter and consequently may disintegrate into 
smaller particles, resulting in a higher apparent microembolic load on TCD.21 Other explanations 
could be that the deployment of the EPD itself causes more emboli, or the EPD does not appose 
the artery optimally, or particles smaller than the pore size of the EPD pass unhindered to the 
brain.25,26  
 In the postprotection phase, after shunt removal and release of the clamps in CEA, retrieval 
of the EPD, or restoration of normal antegrade flow in CAS, no differences could be observed 
between the different treatment strategies. All showed a short burst of emboli, followed by none or 
infrequent particles. 
 Although it is a common finding that CASdp is associated with more intraoperative 
embolization than CEA, direct comparisons may be partially distorted because contrast injection 
occurs only in CAS and generates emboli-like signals that are often picked up by automatic 
detection programs. Because micelles of the contrast agent can generate TCD signals,18 embolic 
loads may be overestimated for CAS. To avoid this problem, we discarded the signals directly 
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related to contrast injection. Nonetheless, CASdp was still associated with a higher embolization 
rate. The reliable detection of embolic events in this study was further confirmed by the high inter-
rater correlations for detecting discrete emboli and embolic showers. 
 As it is unclear whether distal protection filters have a beneficial effect, other cerebral 
protection methods have been proposed, using an antegrade flow stop or even reversal of flow in 
the internal carotid artery.8,27,28 Unfortunately, the clinical benefits of these methods based solely 
on reducing embolic risk are also unclear.29 While comparisons between proximal embolic 
protection and distal protection filters sometimes show contradictory results,29-34 studies using 
direct transcervical access with dynamic flow reversal consistently suggest better outcomes than 
CASdp.6,7 Gupta et al.,11 for example, showed that transfemoral CAS with flow reversal may lower 
embolization rates, although this difference failed to reach significance. Our results show that direct 
cervical access combined with dynamic flow reversal during angioplasty and stenting is able to 
significantly decrease the number of emboli compared to distal filters. In the present study, a 
dynamic flow reversal method is used, where the flow reversal is 10 times as strong in the high-
flow mode and 5 times as strong in the low-flow mode as the Gore flow reversal system (W.L. 
Gore and Associates, Flagstaff, AZ, USA). This, in combination with avoiding aortic arch 
manipulations, explains the current low embolization rate.  
 Some advantages of CASfr compared with CEA are the common use of local anesthesia, 
lower incidences of cranial nerve injury and myocardial infarction, and the short duration of flow 
reversal. A disadvantage is that the proximal ipsilateral CCA should be healthy and ideally 5 cm 
long to obtain safe access. Case selection is done using duplex ultrasound, evaluating both the CCA 
entry point and length. If the neck is obese but there is sufficient CCA length, the procedure can be 
carried out, preferably under general anesthesia, by creating a subcutaneous tunnel to avoid kinking 
of the sheath. Furthermore, a puncture in the femoral vein is also made in addition to a small 
incision in the neck. Around 5% to 10% of patients may experience intolerance to the reverse flow.6 
This can be overcome by increasing blood pressure, minimizing the duration of the reverse flow, 
switching from the high- to low-flow mode, or if necessary, unclamping the CCA and restoring 
normal antegrade flow.6 Although CEA is still considered the gold standard, when for any reason 
CAS is preferred as a better treatment option, CASfr appears to be a safer method than CASdp in 
appropriately selected cases. 
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 Although studies on CASfr are still scarce, it has been shown that transcervical stenting 
with dynamic flow reversal is able to overcome many limitations of transfemoral carotid stenting 
with distal protection filters, revealing stroke and new DW-MRI lesions rates that are comparable 
with CEA.6,7 This study is consistent with these findings, since the embolic load during CASfr was 
comparable with that during CEA.  
 
Limitations 
First, there was no DW-MRI data to confirm the effect of higher embolization rates on new 
structural brain lesions post intervention as shown in previous research.35 Second, the number of 
dropouts due to insonation problems was high, especially in older women, although this is a 
problem inherent to the TCD technique15, 16 and is not specific to this study. A third limitation was 
the limited number of patients.  
 
Conclusion  
CASfr is an effective method to reduce the number of emboli released during carotid 
stenting. In the preprotection phase, CASfr and CEA showed lower embolization rates than CASdp, 
probably because they avoided the aortic arch and provided direct access to the lesion site. During 
the protection phase, CEA and CASfr again had less embolization than CASdp. No significant 
differences between CEA and CASfr could be detected regarding intraoperative embolization. 
Future research examining differences between revascularization techniques as regards 
intraoperative embolization is warranted to confirm our results. 
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General Discussion 
 
The major aim of this thesis was to elucidate the effect of carotid revascularization on 
cognitive functioning. Moreover, the effect of a newer CAS technique - transcervical carotid artery 
stenting with dynamic flow reversal (CASfr) - was evaluated in its ability to reduce perioperative 
embolization compared with conventional CAS using distal protection filters.  
 
In the systematic review of Chapter 1, we showed that none of the selected studies 
comparing CEA and CASdp could find significant differences in cognitive functioning between 
the two treatment modalities. The majority of patients remain cognitively stable after 
revascularization, but a minority (10 to 20%) does experience cognitive alterations. Symptomatic 
status and side of intervention do not appear to influence postoperative cognition while in several 
studies increasing age was a significant predictor of cognitive decline or less improvement than 
expected.1 However, at the same time we unveiled that several methodological issues may 
obfuscate a straightforward interpretation of the data. Especially the failure to implement a control 
group, the lack of information about the symptomatic status and type of symptomatic events, the 
wide variety of cognitive tests and statistical methods used, and sometimes high drop-out rates 
hamper the ability to directly compare different studies or perform a meta-analysis. 
 
In Chapter 2 we confirmed the findings of our review by showing that CEA and CASdp 
have similar effects on cognition, plus we showed that CASfr produces comparable results. We 
used a control group of patients with peripheral arterial disease matched for sex, age, and SES. 
This control group showed comparable baseline cognitive impairments as the treatment group, 
probably because they share similar co-morbidities and risk factors as patients with significant 
carotid artery disease, such as arterial hypertension, hypercholesterolemia, diabetes, and active 
smoking.2 A comparable cognitive baseline status of the control group is important, since subjects 
with a higher IQ are known to benefit more from previous testing – that is, higher baseline IQ 
scores evoke higher practice effects.3 With a healthy control group, the expected practice effects 
may consequently be overestimated which can result in a higher chance of concluding that the 
treated group shows cognitive decline.      
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Recent articles published since our review that respected similar inclusion criteria have 
been studied, but only three included a control group; one CAS study4, one CEA study1, and one 
CEA versus CAS study.5 Interestingly, all three studies recruited carotid patients on best medical 
treatment (BMT) as a control group.  
 
Yoon et al.4 compared 23 CAS patients (12 asymptomatic and 11 symptomatic) with 10 
control patients with a significant carotid stenosis on BMT. Only symptomatic patients seemed to 
benefit from revascularization, while asymptomatic and control cases did not show any cognitive 
changes at three months. The sample size was small and only two out of the 20 tested variables 
showed a difference between symptomatic and asymptomatic patients, which is in contrast with 
previous larger CAS studies.6, 7 Therefore, the results of this study should be interpreted with 
caution. 
 
Carta et al.1 compared 35 patients who underwent CEA (11 symptomatic, 24 asymptomatic) 
with 11 patients (4 symptomatic, 7 asymptomatic) on BMT. After 6 months, 30% of CEA patients 
showed cognitive improvement compared to 0% of patients on BMT. Although a general increase 
in cognitive scores is to be expected due to practice effects, the significant difference between the 
two groups suggests that CEA may improve cognitive functions, at least in a subgroup of carotid 
artery stenosis patients.1 Keep in mind that this study was non-randomized and that patients 
refusing invasive therapy may form a specific subgroup, which could also explain the observed 
cognitive differences between the two groups.  
 
In contrast with Carta et al.1, Wapp et al.5 did not find any differences in cognitive 
performance between 20 CEA, 10 CAS, and 28 patients on BMT at one-year follow-up assessment, 
despite using a comprehensive neuropsychological test battery. Improved cognitive scores were 
noted in all groups, probably due to practice effects. In the control group, improvement was noted 
in fewer tasks than after CEA or CAS, but no significant differences between the groups could be 
detected, suggesting that the effect of invasive treatment on cognition is small.5 This was also a 
non-randomized study.   
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It is obvious that overall, the cognitive impact of revascularization is rather limited. 
Suggesting that every significant asymptomatic carotid artery stenosis should be regarded as 
symptomatic because of cognitive deterioration, and should therefore be revascularized is not 
justified. Nonetheless, a subgroup of 10 to 15% of patients each with significant asymptomatic 
carotid artery stenosis may on one hand be at risk for cognitive decline following intervention or 
may on the other hand benefit from carotid revascularization. Identifying these patients is 
paramount as it may influence the decision to intervene or continue best medical therapy. In case 
of expected cognition deterioration, surgery for asymptomatic patient should be discouraged, while 
in case of expected positive effects, it may be advocated to revascularize these patients. 
 
In Chapter 3 we tried to find predictors of cognitive change, regardless of the type of 
carotid revascularization. S-100β and perioperative embolization as detected by TCD appear not 
able to predict cognitive decline in patients without neurological complications after 
revascularization. It looks like cognitive evolution after revascularization is unpredictable.8 
Although our limited sample size may have caused a type II error, several other studies also failed 
to find associations between S-100β9-12 or embolization8, 13, 14 and cognition after carotid 
revascularization. It appears that changes in serum S-100β are influenced by impairments in the 
blood-brain barrier, which interferes with its ability to predict cognitive deterioration after carotid 
revascularization.12, 15-18  
In the current situation, CASdp results in an almost tenfold higher global embolic load than 
CEA. When looking for a correlation between these extremes and subtle cognitive differences it is 
difficult to find significant associations. Consequently, discarding irrelevant signals is important to 
improve the clinical relevance of TCD monitoring. To this end, differentiation between the size 
and type (gaseous versus particulate) of emboli may play a crucial role.  
 
Similarly, recent studies show that the majority of studies attempting to correlate the size and 
amount of new DW-MRI lesions to postoperative cognition rendered fruitless.19, 20 Although silent 
brain infarctions occur more frequently after CAS than after CEA, this does not seem to have an 
impact on cognitive function one month post intervention.21 An alternative for gray matter damage 
detected by DW-MRI, may be white matter damage detected by diffusion tensor imaging which has 
been shown to correspond with cognitive impairment.22 On the other hand, in a recent ICSS 
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substudy,23 cognitive evolution after 6 months was not related to the severity of white matter lesions 
at baseline. 
 
Changes in cerebral perfusion induced by carotid revascularization have also been linked 
to postoperative cognition. Using computed tomography perfusion, Cheng et al.24 found a close 
relation between perfusion changes and changes in cognitive tests. Patients with a baseline 
impairment of the MCA blood flow were more likely to experience improvement in MCA flow 
after CAS.24 This improvement in MCA blood flow was associated with greater cognitive 
improvement in attention and executive functioning after CEA.25 The repair of a preoperative low 
relative cerebral blood flow in the ipsilateral cerebral hemisphere has been shown to significantly 
improve postoperative cognitive function in patients after CEA.26, 27 Yoshida et al.28 showed that 
increases in cerebral glucose metabolism as measured by positron emission tomography (PET) are 
associated with cognitive improvement after CEA and vice versa. Finally, postoperative 
hyperperfusion is associated with postoperative cognitive decline regardless of the presence any 
new lesions on DW-MRI.22, 29, 30 These studies all seem to suggest that an important link between 
revascularization, cerebral perfusion, and postoperative cognition does exist. 
 
In a recent study31, the hypothesis of changes in brain perfusion as a mediator for cognitive 
improvement after revascularization was studied in patients with a fetal-type (FTP) configuration 
of the posterior part of the circle of Willis. In this variant, the PCA is largely or sometimes 
exclusively supplied by the internal carotid via the posterior communicating artery and less or not 
by the vertebrobasilar system.32 A unilateral or bilateral FTP is found in 12 to 38% of cases.32 Since 
a larger part of the brain is dependent on the blood flow through the internal carotid, patients with 
FTP are more prone to develop vascular insufficiency.31, 32 Carotid revascularization is therefore 
expected to have a higher positive effect since an increased blood flow in the carotid has an effect 
on a larger part of the brain. Nevertheless, the fetal variant was associated with cognitive decline 
instead of improvement after carotid revascularization.31 This is in conflict with the hypothesis that 
improving brain perfusion may enhance cognitive function. However, this correlation between the 
FTP and postoperative cognition does point out that there is a link between carotid 
revascularization, cerebral perfusion, and cognition. A possible explanation may be the selective 
use of shunting. If shunts were seldom used, cerebral ischemia may have occurred due to decreased 
Chapter 5 
96 
 
blood flow during CEA explaining the worse results in the FTP group. Based on this hypothesis, 
the low cerebral blood flow during surgery may have a higher impact than the beneficial effects of 
revascularization. Another explanation for the decline is that revascularization might have caused 
hyperperfusion. Since for FTP patients, the restoration of flow in the internal carotid has a larger 
impact, the brain may not be able to cope with this sudden increase in blood flow resulting in 
hyperperfusion. In any case, the predictors of cognitive alterations after surgery are still not clear. 
It appears difficult to predict cognition after carotid revascularization. Perfusion related measures 
seem promising, but more research is necessary to further elucidate the precise mechanisms for 
cognitive changes. 
 
Chapter 4 focused on the differences in perioperative embolization during various 
revascularization modalities: transcervical access with dynamic flow reversal, filter protected CAS, 
and CEA. It appears that the transcervical stenting causes less embolization before treating the 
lesion site. Avoiding aortic arch and common carotid manipulations proves to be valuable in 
reducing early embolization. Moreover, dynamic flow reversal is able to reduce or avoid 
embolization during stenting and angioplasty as suggested by Ribo et al.33 In the postprotection 
phase, no differences were noted between the three procedures. CASfr has cerebral protection in 
place prior to crossing the carotid lesion and the dynamic flow reversal is more effective in reducing 
embolization and protecting the brain than distal filter protection.  
While comparisons between proximal embolic protection devices and distal protection 
filters sometimes show conflicting results,34-40 studies using direct transcervical access with 
dynamic flow reversal consistently suggest better outcomes than CASdp.41-43 Especially the larger 
sheath and increased reversal flow rate of CASfr may explain its ability to significantly reduce 
embolization.  
 
It is interesting to note that in the same institution CASfr was in Chapter 3 associated with 
a higher embolic load than CEA, while in Chapter 4 CASfr the number of emboli was similar. 
There are several explanations for this ambivalence. Firstly, in Chapter 4, symptomatic stroke 
patients were also included resulting in a larger sample size and higher statistical power. Secondly, 
in Chapter 3, the global embolic load during the entire procedure was measured, while in Chapter 
4, the embolic load was divided in three surgical phases. Thirdly, CASfr patients included in 
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Chapter 3 were the first patients treated at our unit with this new technology and may resemble the 
learning curve associated with this new technology. The increased experience of the vascular 
surgeons and the improved ENROUTE system (Silkroad medical, Sunnyvale, CA), with changes 
to the arterial 8F sheath, may explain the lower embolization rates in those patients treated later 
during these research projects. 
 
Limitations 
 
The main limitation of this research is the small sample size. One could argue that larger 
groups and subsequent statistical power might have allowed us to identify significant group 
differences between the various revascularizations regarding cognitive outcomes. Nonetheless, 
post-hoc power analysis based on the observed performance differences, predicts that 400 to 500 
patients in each group would have had to be included in order to detect significant group 
differences. Although this observation does not exclude the possibility of genuine group 
differences when these sample sizes are reached, it does suggest that possible differences are 
probably modest. This is consistent with other research as described in Chapter 1; none of the 
reviewed studies on the cognitive effects of CEA and CAS showed significant differences between 
the two treatment modalities. This thesis has also studied the effect of CASfr on cognition and 
compared it with CASdp and CEA, but again, no significant differences were noted.  
Similarly, in Chapter 2, the inability to predict cognition post-carotid revascularization 
using TCD and S-100β could be the consequence of low statistical power. But again, several recent 
studies have also been unable to find a similar association.8-10, 13, 14 
 
A second limitation is the nonrandomized design of the studies included in this thesis. This 
design was chosen since randomization is not easy to achieve in carotid revascularization because 
treatment allocation should be patient-specific and depends on comorbidities, anatomical and 
lesion characteristics, and the patient’s preference. Differences in patient characteristics may have 
influenced stroke risk, perioperative embolization, and cognitive abilities. Nonetheless, analysis of 
demographic variables did not show any relevant differences between the treatment groups in any 
of our studies. 
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A third limitation is that our studies lacked DW-MRI data or perfusion measures as assessed 
by PET or SPECT. Especially perfusion measures seem promising in predicting cognitive outcome. 
However, the TCD recordings allowed us to differentiate between the different stages of carotid 
revascularization which provided valuable information to determine which specific surgical acts 
are prone to evoke embolization.   
 
A fourth limitation is the lack of a power calculation before starting the studies. Although 
it would be difficult to estimate the cognitive performance and variances in advance, it might have 
added to the persuasiveness of our data.  
 
Future directions and guidelines 
 
In this thesis, we showed the importance of using a proper control group when studying the 
cognitive sequelae after different carotid revascularization techniques. Practice effects are a major 
limitation in studies without a control group. Although several researchers25, 44 correctly claimed 
that different forms of material (i.e. different sets of the same test) reduce practice effects, even tests 
designed to minimize practice effects such as the RBANS, are prone to practice effects.45 Practice 
effects occur for nearly all tests, especially between the first and second assessment, though the 
frequency and timing of the assessments have an important influence on the size of these effects.45 
Besides the practice effects, patients can become ‘test wise’ which can also result in significantly 
increased test scores over time.46 To avoid alternative explanations, control groups are therefore 
deemed necessary.45  
It is important to not solely compare postoperative test results, as is sometimes performed,47, 
48 but to take baseline measurements into account. Otherwise, postoperative differences between 
groups might be the mere reflection of small differences at baseline. When using difference scores, 
such as subtracting the preoperative test score from the postoperative test score, the real effect of 
the intervention on cognition can be estimated. An ideal control group would comprise patients 
with asymptomatic carotid stenosis since the natural cognitive evolution in patients with significant 
carotid artery stenosis on BMT would be incorporated. Carotid patients not offered 
revascularization may experience cognitive decline over time, while those after carotid 
General discussion and future perspectives 
 
99 
 
revascularization may remain stable. Hypothetically, a stable cognitive status post 
revascularization may be a good result, as further cognitive deterioration is avoided. Therefore, a 
multicenter randomized controlled trial should directly compare cognitive functioning in carotid 
patients randomized between BMT and carotid revascularization. 
 
 When evaluating BMT, it is also important to control for medication adherence, 
especially in patients with an undiagnosed cognitive impairment.49 Identifying patients with limited 
cognitive ability is important to increase supervision for medication intake.49  
 
Based on our findings, several recommendations can be generated that are vital for future 
research about cognition and carotid artery disease. 
Firstly, information about the (a)symptomatic status, the type of cerebral protection used in CAS, 
and type of anesthesia used are often lacking, making it difficult to interpret the results. 
Transparency regarding exclusion criteria is also essential to interpret the findings.  
Secondly, when examining postoperative cognition, it may be useful to differentiate between the 
cognitive domains instead of using a global cognitive sum score. The latter may not be able to pick 
up subtle cognitive differences. Reporting the number of patients improving or deteriorating post-
carotid treatment is paramount since carotid revascularization does not always have the same effect 
in every carotid stenosis patient.  
Thirdly, the statistics used have an important influence on the results reported. Zhou et al.50, for 
example, reported correlations between cognitive outcome on the RAVLT and DW-MRI findings. 
In their study, a sum score of the RAVLT at the follow-up assessment of at least one point lower 
than at baseline was regarded as a deteriorated cognitive function. However, a difference of only 
one point on the total sum score is neither clinically relevant nor statistically significant. These 
arbitral decisions heavily influence the results. Therefore, to define and detect cognitive alteration, 
we advocate using at least one standard deviation difference from the baseline score.  
 Fourthly, several studies investigate the effects of revascularization one day post-treatment. 
Although it may be interesting to study the factors that contribute to these early changes, cognitive 
functioning immediately postoperatively is likely to be influenced by other factors not directly 
related to revascularization such as the type or duration of anesthesia. Moreover, the clinical 
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relevance of these early cognitive changes for patients is probably limited. Thus, we would 
recommend to assess cognitive functioning at least five days post intervention.  
Fifthly, when examining cognitive function it is important to perform a comprehensive testing. 
Short screening instruments, such as the MMSE and MOCA, are insufficient and may for example 
result in the fact that only memory function is tested, while visuomotor or executive functions are 
neglected. Moreover, these short testing instruments are prone to ceiling effects, as many patients 
achieve the maximum score on the MMSE. Screening instruments like the MMSE have been 
devised to detect major cognitive disorders (dementia), not to assess milder cognitive impairment. 
It has been shown that floor and ceiling effects may influence the observed cognitive outcomes 
after carotid revascularization.51  
 
As stated above, surgical techniques and best medical treatment are constantly evolving. 
Consequently, when reviewing the literature of carotid revascularization, it is important to focus 
on recent publications. Stroke and death risks in CAS have decreased from 1993 to 2006 which is 
due to better case selection, improved medical treatment, development of newer stenting and 
cerebral protection devices, technical advances, and better training curricula.52 Furthermore, older 
publications53, 54 are more likely to report positive results in contrast with recent studies. As 
suggested previously54, this may be the result of fewer methodological biases in more recent studies. 
Thus it is advisable to directly compare surgical techniques rather than with historical data to avoid 
a flawed comparison. 
 
The issue whether to treat asymptomatic carotid patients is still a matter of debate. Expected 
cognitive outcomes may play an important role in the decision-making. Large prospective 
multicenter longitudinal studies on the cognitive effects of carotid revascularization are needed and 
the link between improved perfusion in the brain and cognition should be further explored. 
Focusing on cognitive effects of revascularization in subgroups of patients, such as carotid patients 
with the fetal-type variant of the circle of Willis, may prove useful in testing hypotheses that arise 
from correlation studies.   
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Summary  
  
Carotid artery stenosis has been identified as an important risk factor for stroke. To reduce 
the stroke risk, carotid endarterectomy (CEA) is often performed and proven safe and effective in 
symptomatic as well as asymptomatic carotid stenosis patients. CAS with distal filter protection 
(CASdp) is proposed as an alternative for CEA, especially in high-risk patients, and is associated 
with a lower incidence of cranial nerve injury and myocardial infarction. However, stroke and new 
diffusion-weighted magnetic resonance imaging (DW-MRI) lesions are more prevalent when 
compared with CEA. Transcervical CAS with dynamic flow reversal (CASfr) is a newer technique 
designed to provide a more direct access to the lesion site and reduce embolization. Results show 
a low stroke rate and reduced number of DW-MRI lesions when compared with CASdp. Besides 
these primary outcome measures, the effect of carotid revascularization on cognition is not clear. 
Moreover the effect of CASfr on postoperative cognition has not been studied thoroughly.   
 
In Chapter 1 we performed a systematic review of the literature since 2007 trying to clarify 
the effect of carotid revascularization on cognition. This emphasis on recent literature was made to 
ensure that the included studies used the more advanced revascularization techniques, devices, and 
BMT in order to provide a high ecological validity. Only studies that implemented a comprehensive 
neuropsychological testing and performed assessments at least five days post-treatment were 
included. Furthermore, we focused on studies using a control group to ensure the emphasis of the 
review was on methodologically solid studies. The systematic review showed that CEA and CASdp 
have a similar effect on cognition post intervention; no significant differences could be observed 
between the two treatment modalities in any of the reviewed studies. However, a subgroup of 
patients may experience either improvement or deterioration.  
 
In Chapter 2, the results of a comparative study are described in which we studied the 
effects of CEA and two forms of CAS (CASdp and CASfr) on cognition. With all three methods, 
similar results were obtained. Patients with peripheral arterial disease (PAD) were recruited as 
controls. Both the control and study groups showed cognitive dysfunction at baseline, probably 
due to similar risk factors such as current smoking, hypercholesterolemia, hypertension, diabetes, 
and so on. The similarity between our controls and carotid patients, especially in baseline cognitive 
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status, prevents confounding factors that arise in studies using healthy controls as a comparison. 
Finally, as also found in the review, our study unveiled that a subgroup of around 10 to 15% 
presented cognitive improvement, while another subgroup of the same size showed cognitive 
deterioration. 
 
Identifying patients at risk for cognitive decline or susceptible for improvement is a 
challenge. In Chapter 3 we have attempted to identify those patients with cognitive deterioration 
post intervention by using S-100β and perioperative embolization levels. These two variables were 
unable to reliably predict cognitive decline. Although the numbers in our study were limited, other 
recent studies were also unsuccessful in predicting cognition using these same variables. The 
transient increase in S-100β, observed in all revascularization therapies, was most likely the 
consequence of impairment in the blood-brain barrier.  
CASdp was associated with a higher embolic load than CASfr and CEA. Nonetheless, the 
impact of this embolic load on cognitive outcomes remains unclear. Differentiation between emboli 
regarding their size and type (particulate versus gaseous) may improve the clinical relevance of 
TCD monitoring. Perfusion related measures are promising, but the mechanisms by which 
revascularization results in either mitigation of previous hypoperfusion or in postoperative 
hyperperfusion are poorly understood.  
  
Chapter 4 zoomed in on perioperative embolization during various phases of the carotid 
revascularization. In the preprotection phase, CASfr and CEA caused lower embolization rates than 
CASdp, most likely because they provide a direct access to the lesion site. Likewise, in the 
protection phase, CASfr and CEA caused a significantly lower embolic load than CASdp. The 
dynamic flow reversal appears to better protect the brain against emboli during CAS than the distal 
embolic protection filters. In the postprotection phase, no differences could be observed between 
the three procedures. We showed that CASfr is effective to reduce the embolic load during 
angioplasty and stenting with similar embolic levels as CEA. Combined with previous stroke and 
DW-MRI studies, our data suggest that when a surgeon decides to perform CAS and the anatomy 
is suitable, CASfr may be a safer treatment option. 
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Research on the cognitive effects of carotid revascularization will remain important. Since 
the mere presence of a significant carotid stenosis is a predictor of cognitive dysfunction, assessing 
the effect of revascularization on cognition is essential. If patients are at risk for further cognitive 
decline, the surgeon may decide not to intervene in asymptomatic patients, while if cognitive 
improvement is expected, decision-making may be straightforward. 
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Beroertes zijn een belangrijke oorzaak van sterfte en functionele beperking in onze 
maatschappij. Carotisstenose, de vernauwing van de interne halsslagader, is een belangrijke 
risicofactor voor beroerte waarbij het risico toeneemt met de graad van de stenose. Een stenose 
komt voor wanneer plaque zich opbouwt in de carotis interna. Deze plaque bestaat uit vet, 
cholesterol, calcium, en andere bestanddelen uit het bloed. Deze plaque wordt mettertijd harder en 
kan de carotis vernauwen of zelfs blokkeren wat kan zorgen voor een verminderde bloedtoevoer 
naar de hersenen. Daarnaast kunnen ook kleine stukjes van de plaque afbreken en in de hersenen 
vast komen te zitten in een kleiner bloedvat waardoor eveneens een beroerte veroorzaakt kan 
worden. Het risico op een carotisstenose stijgt voor zowel mannen als vrouwen met de leeftijd en 
zal dus met de toegenomen levensverwachting een steeds belangrijker probleem worden.  
 
Om het risico op beroerte te verminderen, wordt carotis endarterectomie (CEA) uitgevoerd 
bij patiënten die symptomen hebben als gevolg van de stenose zoals al dan niet tijdelijke 
verlammingsverschijnselen, maar ook bij asymptomatische patiënten. Tijdens CEA wordt de 
binnenste laag van de carotis, intima en delen van media, weggenomen. Carotis stenting is een 
alternatief voor CEA, meer specifiek voor hoog-risico patiënten, en vermindert de kans op schade 
aan de hersenzenuwen en myocard infarct. Tijdens CAS wordt een punctie gemaakt in de femorale 
arterie een katheder endovasculair geleid via de aortaboog naar de carotis waar de stent geplaatst 
wordt en indien nodig ballondilatatie uitgevoerd kan worden. Vaak wordt er, om de hersenen te 
beschermen tegen embolisatie tijdens de procedure, aan de distale kant van de stenose een 
zogenaamd embolic protection device gebruikt. Dit is een openklapbare filter ontworpen om debris 
afkomstig van de plaque op te vangen. Alhoewel zowel CEA en CAS veilig bevonden zijn, blijkt 
CAS met distale filters (CASdp) geassocieerd met een hogere prevalentie van letsels op 
hersenbeeldvorming en een verhoogd risico op beroerte in vergelijking met CEA. 
 
Met als doel het risico op beroertes en laesies te verminderen zijn andere 
beschermingsmethodes ontwikkeld zoals stenting met een transcervicale toegang en omkering van 
de bloedstroom in de behandelde carotis (CASfr). In plaats van de katheder omhoog te leiden vanuit 
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de femorale arterie wordt er een kleine incisie in de hals gemaakt en de stent zo rechtstreeks 
geplaatst. Daarnaast wordt er een arterioveneuze shunt gemaakt tussen de carotis communis en de 
vena femoralis en zal de bloedstroom in de behandelde carotis tijdens de interventie omgekeerd 
worden om het debris afkomstig van de plaque weg te leiden van de hersenen. 
  
De effecten van CEA en CAS op cognitie zijn het onderwerp van een steeds groeiend 
onderzoeksveld. Carotis revascularisatie kan leiden tot cognitieve achteruitgang door perioperatieve 
embolisatie of onderbreking van de bloedstroom. Daarentegen kan het verwijderen van een stenose 
en de daaruit volgende verbetering van de bloedsdoorstroming naar de hersenen resulteren in een 
cognitieve verbetering. Het is tot op heden niet duidelijk welk netto effect revascularisatie heeft op 
cognitie.   
 
Om het effect van carotis revascularisatie op cognitie na te gaan hebben we in Hoofdstuk 
1 een systematische review uitgevoerd van alle publicaties sinds 2007. De focus werd gelegd op 
recente artikels omdat de medische technieken en standaard medische therapie (bv statines) steeds 
evolueren en het daarom belangrijk is vooral te kijken naar de meest recente studies aangezien deze 
een betere reflectie zijn van de huidige medische realiteit. Daarnaast werden studies enkel 
geïncludeerd wanneer ze een uitgebreide neuropsychologische testing omvatten en zich niet 
beperkten tot korte screeningsinstrumenten. Om de effecten van anesthesie te vermijden werden 
verder studies enkel geselecteerd indien de cognitieve testings na 5 dagen of meer plaatsvonden. 
Tot slot was er een duidelijke focus op studies die controlegroepen gebruiken. Dat is belangrijk 
omdat door gebruik te maken van een controlegroep, de studie rekening kan houden met 
oefeneffecten. Hoe vaker iemand een bepaalde test aflegt, hoe beter diens prestatie zal zijn, los van 
de onderliggende cognitieve functies. Uit de review bleek dat er geen duidelijke significante 
verschillen zijn tussen CEA en CASdp wat betreft hun effect op cognitie. Er blijken wel subgroepen 
van 10 a 15% van de patiënten te zijn die cognitieve verbetering dan wel achteruitgang tonen, los 
van de specifieke soort revascularisatie die gebruikt werd. 
 
In Hoofdstuk 2 werden deze resultaten geëxtrapoleerd naar CASfr. CEA, CASdp en CASfr 
resulteerden in gelijkaardige veranderingen in cognitie. Als controlegroep werden patiënten met 
perifeer arterieel lijden (PAD) gerekruteerd. Zowel de patiënten met PAD als de patiënten met 
Samenvatting 
110 
 
carotis stenose blijken al tijdens de baseline meting cognitieve problemen te vertonen. Dat is 
hoogstwaarschijnlijk het gevolg van gemeenschappelijke factoren zoals hypercholesterolemie, 
hypertensie, diabetes, roken, enz. Deze gelijkaardige baseline is belangrijk omdat aangetoond werd 
dat personen met een hoger IQ een hoger oefeneffect kunnen vertonen bij herhaalde testingen. In 
deze studie vonden we, in overeenstemming met de review, dat 10 a 15% van de carotispatiënten 
cognitieve verbetering of achteruitgang ondervindt wanneer we ze vergelijken met de 
controlepatiënten.  
  
In Hoofdstuk 3 probeerden we te achterhalen of het eiwit S-100β en de perioperatieve 
embolisatie zoals gedetecteerd door transcranieel Doppler (TCD) monitoring ons in staat stellen 
om te voorspellen welke patiënten cognitieve achteruitgang zullen vertonen. Cognitieve 
achteruitgang kon in deze studie echter niet voorspeld worden. Alhoewel deze resultaten mogelijks 
verklaard zouden kunnen worden door de kleine steekproef en dito statische kracht van het 
onderzoek, blijken ook andere studies niet in staat een relatie te vinden tussen S-100β, 
perioperatieve embolisatie en cognitie. Een lichte tijdelijke toename in S-100β werd gedetecteerd 
voor alle interventies en is waarschijnlijk het gevolg van een wijziging in de bloed-hersen-barrière. 
Verder was CASdp geassocieerd met een hogere embolisatie tijdens de operatie vergeleken met 
CASfr en CEA, maar de klinische relevantie hiervan m.b.t. postoperatieve cognitie is evenmin 
duidelijk. Indien toekomstige technologische verbeteringen ons toelaten om te differentiëren tussen 
embolen volgens hun grootte en aard (gasvormig versus vast), zal de klinische relevantie van TCD 
monitoring waarschijnlijk verder verbeterd kunnen worden. Het identificeren van patiënten die 
vatbaar zijn voor cognitieve veranderingen zal een belangrijk topic blijven. Mogelijk hebben 
perfusiegerelateerde criteria meer kans om succesvol deze patiënten te identificeren. 
 
In Hoofdstuk 4 gingen we verder in op de embolisatie tijdens de verschillende chirurgische 
fasen van de interventie. In de fase voordat de cerebrale bescherming - zoals de distale filters of 
omkering van de bloedstroom - geïnstalleerd is, blijken CASfr en CEA reeds minder embolisatie 
te veroorzaken dan CASdp. Dit is waarschijnlijk het gevolg van het feit dat de eerste twee direct 
toegang tot de plaats van de laesie bieden, terwijl bij CASdp er een hele weg via de arteria 
femoralis, aortaboog naar de carotis afgelegd moet worden. Het manipuleren van de wires en 
botsen tegen de wand van aangetaste bloedvaten kan ervoor zorgen dat er tijdens die fase reeds 
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embolisatie voorkomt. Ook tijdens de fase waarin de cerebrale bescherming aanwezig is, blijken 
CEA en CASfr beter te presteren dan CASdp. De omkering van de bloeddoorstroming in de carotis 
blijkt dus effectiever te zijn in het reduceren van embolisatie tijdens het stenten en de ballondilatatie 
dan de distale filters. In de laatste fase, na het verwijderen van de cerebrale bescherming, resulteren 
alle revascularisatietherapieën in gelijkaardige embolisatieniveaus. CASfr blijkt dus globaal beter 
te presteren dan CASdp in het reduceren van perioperatieve embolisatie en lijkt dus de aangewezen 
optie indien een chirurg beslist om carotis stenting uit te voeren. 
 
Onderzoek naar de cognitieve gevolgen van carotis revascularisatie zal een belangrijk 
onderwerp voor toekomstig onderzoek blijven. De aanwezigheid van een significante 
carotisstenose heeft een impact op cognitie en het nagaan van de effecten van revascularisatie is 
daarom relevant. In een ideaal scenario zou de beslissing om chirurgisch in te grijpen, zeker in het 
geval van asymptomatische patiënten, mee kunnen bepaald worden door het verwachte effect op 
de cognitieve functies. Bij patiënten bij wie een positief effect op cognitief vlak verwacht wordt, 
kan dan beslist worden in te grijpen terwijl er bij patiënten bij wie een negatief effect verwacht 
wordt een meer terughoudende houding kan worden aangenomen.
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Appendix 
Cognitive domains and neuropsychological tests. 
Cognitive Domain and 
Neuropsychological Test 
Description 
Long-term memory  
AVLT, Sum Participants are given a list of 15 unrelated words repeated by 
the examiner over five different trials and are each time asked to 
repeat. 
AVLT, delayed recall First a list of 15 unrelated words are given. Subsequently the 
participant is asked to repeat the original list of 15 words and 
then again after 45 minutes.  
CFT, delayed recall Participants are given a complex figure which they have to copy. 
Afterwards they must draw the figure from memory and then 
again after 45 minutes. 
Attention  
SS (forwards)  In this task the participant has to mimic the examiner as he/she 
taps a sequence of up to nine identical spatially separated blocks. 
The sequence starts out simple, using two blocks, but becomes 
more complex until the subject's performance suffers.  
DS (forwards)  In this task the participant has to repeat a sequence of up to nine 
numbers. Also in this case, the sequence starts out simple, using 
two numbers, and becomes increasingly difficult.  
SS-C  This test consists of nine digit-symbol pairs followed by a list of 
digits. Under each digit the participant has to write down the 
corresponding symbol as fast as possible. 
D-2 In this task participants have to cross out any letter ‘d’ with two 
marks around. The surrounding distractors are similar to the 
target stimulus, such as a ‘p’ with two marks or a ‘d’ with one or 
three marks. 
TMT-A For this test the participant is instructed to connect a set of 25 
dots in sequential order as quickly as possible.  
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Executive functioning  
SS (backwards)  This is identical as the Spatial Span task, but in this case, the 
participant has to repeat the sequence in backward order. 
DS (backwards)  This is identical as the Digit Span task, but in this case, the 
participant has to repeat the sequence in backward order. 
SCWT  For this test, the participant gets presented several color names 
each printed in a different color ink. The participant has to name 
ink colors as quickly as possible. 
Phonological verbal fluency, 
COWAT 
In this case participants have to name as many words as possible 
from a phonemic category, such as words beginning within the 
letter ‘N’, within 60 seconds. 
Semantic verbal Fluency  
from the GIT 
In this case participants have to name as many words as possible 
from a semantic category, such as animals or fruits, within 60 
seconds. 
TMT-B This is identical as the Trail Making Test Part A, but in this case, 
the participant has to alternate between numbers and letters (1, 
A, 2, B, etc.). 
Fine Motor Abilities  
Grooved Pegboard Left/Right Participants are asked to put pegs in holes as fast as possible 
with either their left or right hand 
Spatial Functioning  
Judgement of Line Orientation For this test, participants are asked to match two angled lines to 
a set of 11 lines that are arranged in a semicircle. 
Line Bisection Task In this test, several horizontal lines are presented. The 
participant is asked to dissect the line at the midpoint 
AVLT = Auditory Verbal Learning test; CFT = Complex Figure Task; SS = Spatial Span from the Wechsler 
Memory Scale-III (WAIS-III); DS = Digit Span from the WAIS-III; SS-C = Symbol Substitution coding task from 
the WAIS-III; D-2 = d2 Test of Attention; TMT = Trail Making Test (Parts A and B); SCWT = inference factor of 
the Stroop Color and Word Test; COWAT = Controlled Oral Word Association Test (letters NAK); GIT = 
Groninger Intelligence Test. 
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